|
GenusPlus Group Ltd is an end-to-end specialist service provider for essential power, rail, and communications infrastructure operating across Australia. The company designs, builds, and maintains electrical transmission and distribution networks, substations, rail systems, and battery storage solutions. Its services cover the full project life-cycle, including engineering, design, EPC/turnkey delivery, construction, testing, commissioning, shutdowns, maintenance, and decommissioning. Genus also delivers integrated communication network solutions, encompassing fixed and wireless infrastructure supported by real-time network management. The firm supports customers in integrating new generation technologies into traditional networks and offers environmental and vegetation management services. Key clients include utilities, government agencies, renewable energy developers, and major resource companies. Notable projects include the Millstream 220kV Substation and the Western Renewables Link. Founded in Western Australia, the company has expanded into a national provider with capabilities across the power, utilities, and communications sectors. Summarised from the company's own disclosures, fiscal year ended Jun 2026 |
Industry Capital Goods | Homepage genus.com.au |
| Sector Industrials | IR page ir.miraqle.com | |
|
Tags
power infrastructure, transmission networks, distribution networks, substations, rail infrastructure, battery systems, communications infrastructure, renewable energy, vegetation management, epc, asset maintenance, Millstream 220kV Substation, Western Renewables Link
|
Press page — |
Metrics
| Valuation | |
|---|---|
| Market cap | A$ 1.716B |
| Market cap (USD) | $ 1.193B |
| P/E | 31.03 |
| PEG | 0.57 |
| P/BV | 5.50 |
| P/S | 1.34 |
| P/OCF | 8.85 |
| P/FCF | — |
| Dividend yield | — |
| Turnover / mcap | — |
| Returns | |
|---|---|
| ROE | 17.6% |
| ROI | 12.3% |
| ROIC | 18.5% |
| Profit margin | 3.8% |
| Growth | |
|---|---|
| Revenue growing | Yes |
| Profits growing | Yes |
| Revenue up 3y | Yes |
| Revenue up 5y | No |
| Earnings growth 3y (net profit CAGR) | 54.6% |
| Quality | |
|---|---|
| Profitable | Yes |
| Margin expanding | No |
| Buying back stock | No |
| Diluting (TTM) | Yes |
| Debt/Equity | — |
| Podcast bulls (TTM) | Sign up |
| Podcast bears (TTM) | Sign up |
| Podcast sentiment (TTM) | Sign up |
| Podcast sentiment % (TTM) | Sign up |
| News sentiment (TTM) | 0 |
| Quality score | 23.5% |
| Insiders | |
|---|---|
| Buys, 1w | Sign up |
| Buys, 1m | Sign up |
| Buys, 1y | Sign up |
| Sells, 1w | Sign up |
| Sells, 1m | Sign up |
| Sells, 1y | Sign up |
Podcast Mentions
Announcements lodged with ASX, newest first, routine forms (director and substantial-holding notices, daily buy-back and quotation notices) included. The link opens the announcement on ASX. Press releases from the company's own website, newest first.
GenusPlus Group Ltd (ASX: GNP) (GenusPlus or the Company) provides the following update in relation to the composition of its Board and Board Committees as part of its broader strategy for Board renewal and succession planning. Retirement of Mr Paul Gavazzi Non-Executive Director Mr Paul Gavazzi will retire from the Board with effect from the conclusion of the Company’s 2026 Annual General Meeting (AGM) to pursue his personal interests. GenusPlus Chair Mr Simon High thanked Mr Gavazzi for his contribution to the Company: “On behalf of the Board, I would like to thank Paul for his valued contribution and commitment to GenusPlus during his 9 years as a Director. Paul has brought considerable experience and insight to the Board and, in particular, has made an important contribution through his role as Chair of the Audit & Risk Committee. We wish Paul all the very best for the future.” Mr Gavazzi said: “It has been a privilege to serve on the Board of GenusPlus and to have been part of the Company’s journey. I am proud of what GenusPlus has achieved and believe the Company is well positioned for the future. I would like to thank my fellow Directors, management and the broader GenusPlus team for their support during my time on the Board, and I wish the Company continued success.” Appointment of Ms Debra Counsell The Board is pleased to announce the appointment of Ms Debra Counsell as a Non-Executive Director of GenusPlus with effect from 21 November 2026. Ms Counsell is an experienced company director and former senior executive with more than 30 years’ global experience across the energy, infrastructure, mining and resources, heavy industry and manufacturing sectors. Most recently, she served as Chief Legal Officer and Company Secretary of BlueScope Steel Limited. Ms Counsell has extensive legal, commercial and transactional experience encompassing major projects and procurement, project finance, infrastructure, mergers and acquisitions and joint ventures. She is currently a Non-Executive Director of Bellevue Gold, (ASX:BGL) ASC Pty Ltd (Australia’s submarine builder and sustainer) and Nexus Hospitals, and is a graduate of the Australian Institute of Company Directors, a
08 9390 6999 Level 1, 63-69 Abernethy Road, Belmont WA 6104 www.genus.com.au GenusPlus Group Ltd | ABN 86 620 283 561
1
ASX Release 30 October 2026 For immediate release to the market
member of Chief Executive Women and a Fellow of the Cranlana Institute for Ethical Leadership. Mr High said: “We are very pleased to welcome Debra to the GenusPlus Board. Debra brings extensive experience and capabilities that will complement the existing skills of the Board, and we look forward to her contribution as GenusPlus continues to execute its strategy and pursue its growth objectives.” Ms Counsell said: “I am delighted to be joining the GenusPlus Board and look forward to working with Simon, my fellow Directors and the management team. GenusPlus has built a strong business with exciting opportunities ahead, and I look forward to contributing to the Company’s continued growth and success.” Board Committee changes Following the conclusion of the 2026 AGM, Mr José Martins will succeed Mr Gavazzi as Chair of the Audit & Risk Committee. At the same time, Mr Tony Narvaez will succeed Mr Martins as Chair of the Remuneration & Nominations Committee. Ms Counsell will join these committees. The Board believes these changes provide for an orderly transition of responsibilities and appropriate continuity in the leadership of its Board Committees. The Board of the Company has authorised the release of this announcement to the market.
National essential power and communications infrastructure provider GenusPlus Group Ltd (ASX: GNP) (Genus or the Company) refers to the Share Purchase Agreement announced on 12 October 2026 relating to acquisition of Universal Communications Group Holdings Limited (UCG) (Acquisition). Genus is pleased to advise that it has today completed the Acquisition. UCG is a leading New Zealand based telecommunications construction and maintenance service provider to Tier 1 telecommunication network owners in New Zealand and the Pacific Islands. The Acquisition adds scale and capability to Genus’ telecommunications offering provides and Genus with a platform of scale to drive further growth in New Zealand across telecommunications and other critical infrastructure sectors, The upfront consideration for the Acquisition was funded through the Company’s existing cash reserves and debt facility.
Appendix 2A - Application for quotation of securities
Announcement Summary
Entity name GENUSPLUS GROUP LTD Announcement Type New announcement Date of this announcement Thursday October 29, 2026 The +securities to be quoted are: +Securities issued under an +employee incentive scheme that are not subject to a restriction on transfer or that are to be quoted notwithstanding there is a restriction on transfer Total number of +securities to be quoted ASX +security code
Security description
GNP
ORDINARY FULLY PAID
Number of +securities to be quoted
Issue date
497,889
29/10/2026
Refer to next page for full details of the announcement
Appendix 2A - Application for quotation of securities
1/7
Appendix 2A - Application for quotation of securities
Part 1 - Entity and announcement details
1.1 Name of entity GENUSPLUS GROUP LTD We (the entity named above) apply for +quotation of the following +securities and agree to the matters set out in Appendix 2A of the ASX Listing Rules. 1.2 Registered number type
Registration number
ACN
620283561
1.3 ASX issuer code GNP 1.4 The announcement is New announcement 1.5 Date of this announcement 29/10/2026
Appendix 2A - Application for quotation of securities
2/7
Appendix 2A - Application for quotation of securities
Part 2 - Type of Issue
2.1 The +securities to be quoted are: +Securities issued under an +employee incentive scheme that are not subject to a restriction on transfer or that are to be quoted notwithstanding there is a restriction on transfer 2.2 The +class of +securities to be quoted is: Additional +securities in a class that is already quoted on ASX ("existing class")
Appendix 2A - Application for quotation of securities
3/7
Appendix 2A - Application for quotation of securities
Part 3B - number and type of +securities to be quoted (existing class) where issue has not previously been notified to ASX in an Appendix 3B
Additional +securities to be quoted in an existing class issued under an +employee incentive scheme FROM (Existing Class) ASX +security code and description GNPAB : PERFORMANCE RIGHTS
TO (Existing Class) ASX +security code and description GNP : ORDINARY FULLY PAID
Please state the number of +securities issued under the +employee incentive scheme that are not subject to a restriction on transfer or that are to be quoted notwithstanding there is a restriction on transfer 497,889 Please provide details of a URL link for a document lodged with ASX detailing the terms of the +employee incentive scheme or a summary of the terms https://asx.api.cmfyapp.com/asx-research/1.0/file/2924-02728673-6A1175610&v=undefined Are any of these +securities being issued to +key management personnel (KMP) or an +associate Yes Provide details of the KMP or +associates being issued +securities Name of KMP
Name of registered holder
Number of +securities
David Fyfe
David Fyfe
9,817
George Lloyd
George Lloyd Pty Ltd <George Lloyd a/c>
102,476
Michael Green
Michael John Green and Tricia Lee-Anne Green <Green Family a/c>
94,494
Strati Gregoriadis
Efstratios Vassilios Gregoriadis
67,693
Stewart Furness
Stewart Paul Furness
61,760
Damian Wright
D R Wright Pty Ltd <Wright Family a/c) 98,933
Issue date 29/10/2026 Will the +securities to be quoted rank equally in all respects from their issue date with the existing issued +securities in that class? Yes
Appendix 2A - Application for quotation of securities
4/7
Appendix 2A - Application for quotation of securities Issue details
Number of +securities to be quoted 497,889 Are the +securities being issued for a cash consideration? No Please describe the consideration being provided for the +securities 497,889 ordinary securities issued pursuant to the exercise of 497,889 unlisted performance rights, each with a nil exercise price Please provide an estimate (in AUD) of the value of the consideration being provided per +security for the +securities to be quoted 7.670000 Any other information the entity wishes to provide about the +securities to be quoted
Appendix 2A - Application for quotation of securities
5/7
Appendix 2A - Application for quotation of securities
Part 4 - Issued capital following quotation
Following the quotation of the +securities the subject of this application, the issued capital of the entity will comprise: The figures in parts 4.1 and 4.2 below are automatically generated and may not reflect the entity's current issued capital if other Appendix 2A, Appendix 3G or Appendix 3H forms are currently with ASX for processing. 4.1 Quoted +securities (total number of each +class of +securities quoted on ASX following the +quotation of the +securities subject of this application) ASX +security code and description
Total number of +securities on issue
GNP : ORDINARY FULLY PAID
204,095,049
4.2 Unquoted +securities (total number of each +class of +securities issued but not quoted on ASX) ASX +security code and description
Total number of +securities on issue
GNPAB : PERFORMANCE RIGHTS
1,195,518
GNPAC : SHARE APPRECIATION RIGHTS
1,153,126
GNPAA : RETENTION RIGHTS
Appendix 2A - Application for quotation of securities
35,914
6/7
Appendix 2A - Application for quotation of securities
Part 5 - Other Listing Rule requirements
5.1 Are the +securities being issued under an exception in Listing Rule 7.2 and therefore the issue does not need any security holder approval under Listing Rule 7.1? Yes 5.1a Select the number of the applicable exception in Listing Rule 7.2 13
Appendix 2A - Application for quotation of securities
7/7
ule 3.19A.2
Appendix 3Y Change of Director’s Interest Notice
Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public. Introduced 30/09/01 Amended 01/01/11
Name of entity
GENUSPLUS GROUP LTD
ABN
86 620 283 561
We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act. 0B
Name of Director
Date of last notice
Simon Robert High
16 December 2020
Part 1 - Change of director’s relevant interests in securities
In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.
Direct or indirect interest
Nature of indirect interest (including registered holder)
Note: Provide details of the circumstances giving rise to the relevant interest.
Date of change
No. of securities held prior to change Class Number acquired Number disposed Value/Consideration
Note: If consideration is non-cash, provide details and estimated valuation
No. of securities held after change
- See chapter 19 for defined terms. 01/01/2011
Indirect interest
Simon Robert High 26 October 2026
304,167
Fully paid ordinary shares 32,000
Nil
$245,625.57
336,167
Appendix 3Y Page 1
Appendix 3Y Change of Director’s Interest Notice Nature of change
Example: on-market trade, off-market trade, exercise of options, issue of securities under dividend reinvestment plan, participation in buyback
On market trade.
Part 2 – Change of director’s interests in contracts Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.
Detail of contract
Nature of interest Name of registered holder (if issued securities) Date of change No. and class of securities to which interest related prior to change Note: Details are only required for a contract in relation to which the interest has changed
Interest acquired
Interest disposed Value/Consideration
Note: If consideration is non-cash, provide details and an estimated valuation
Interest after change
Part 3 – +Closed period Were the interests in the securities or contracts detailed No above traded during a +closed period where prior written clearance was required? If so, was prior written clearance provided to allow the N/A trade to proceed during this period? If prior written clearance was provided, on what date was N/A this provided?
- See chapter 19 for defined terms. Appendix 3Y Page 2
01/01/2011
ule 3.19A.2
Appendix 3Y Change of Director’s Interest Notice
Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public. Introduced 30/09/01 Amended 01/01/11
Name of entity
GENUSPLUS GROUP LTD
ABN
86 620 283 561
We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act. 0B
Name of Director
Date of last notice
David William Riches 10 March 2026
Part 1 - Change of director’s relevant interests in securities
In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.
Direct or indirect interest
Nature of indirect interest (including registered holder)
Note: Provide details of the circumstances giving rise to the relevant interest.
Date of change
No. of securities held prior to change
Indirect interest
David William Riches and Matthew Steven Riches ATF Dave Riches and Matt Riches Unit Trust - Trustee and beneficiary 21 October 2026
78,922,947 (direct)
Matthew Steven Riches & David William Riches – 11,766,652 (indirect) Class Number acquired Number disposed Value/Consideration
Note: If consideration is non-cash, provide details and estimated valuation
- See chapter 19 for defined terms. 01/01/2011
Dave Riches Pty Ltd – 1,861,000 (indirect) Fully paid ordinary shares 62,000
Nil
$492,403.37
Appendix 3Y Page 1
Appendix 3Y Change of Director’s Interest Notice No. of securities held after change
78,922,947 (direct)
Matthew Steven Riches & David William Riches – 11,766,652 (indirect)
Nature of change
Example: on-market trade, off-market trade, exercise of options, issue of securities under dividend reinvestment plan, participation in buyback
Dave Riches Pty Ltd – 1,923,000 (indirect) On market trade.
Part 2 – Change of director’s interests in contracts Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.
Detail of contract
Nature of interest Name of registered holder (if issued securities) Date of change No. and class of securities to which interest related prior to change Note: Details are only required for a contract in relation to which the interest has changed
Interest acquired
Interest disposed Value/Consideration
Note: If consideration is non-cash, provide details and an estimated valuation
Interest after change
Part 3 – +Closed period Were the interests in the securities or contracts detailed No above traded during a +closed period where prior written clearance was required? If so, was prior written clearance provided to allow the N/A trade to proceed during this period? If prior written clearance was provided, on what date was N/A this provided?
- See chapter 19 for defined terms. Appendix 3Y Page 2
01/01/2011
21 October 2026
GenusPlus Group Ltd (ASX: GNP) Notice of Annual General Meeting and Proxy Form Dear Shareholder, GenusPlus Group Ltd (Company) is convening the Annual General Meeting of shareholders to be held at the offices of Grant Thornton, Level 43, 152 -158 St Georges Terrace, Perth Western Australia on Friday 20 November 2026 at 10:00am (WST) (Meeting). In accordance with the Treasury Laws Amendment (2021 Measures No.1) Act 2021, the Company will not be sending hard copies of the Notice of Meeting (Notice) unless a shareholder has requested a hard copy. The Notice is available on the company's website at https://genus.com.au/asx-announcements Voting You may vote by attending the Meeting in person, by proxy, or by appointing an authorised representative. Shareholders are encouraged to vote on the business of the Meeting. Voting in Person To vote in person attend the Meeting on the date and at the place as set out above. If possible, Shareholders are asked to arrive at the venue 15 minutes prior to the time designated for the Meeting, so that the company may check the Shareholder’s holding against the Company’s share register and note attendance. Voting by Proxy A copy of your personalised proxy form is enclosed for convenience. Proxy votes may also be lodged online by using the link below: •
https://au.investorcentre.mpms.mufg.com/Login/Login
•
Log in to the MUFG website, using the details as shown on the Proxy Form.
•
Select ‘voting’ and follow the prompts to lodge your vote. To use the online lodgement facility, shareholders will need their Security Reference Number (SRN) or Holder Identification Number (HIN) as shown on the front of the Proxy Form.
Proxy forms must be received by 9:00am WST on Wednesday 18 November 2026. If you have any difficulties obtaining a copy of the Notice please contact the Company on +61 8 9390 6999. Shareholder Questions Shareholders are encouraged to submit their questions to the board that relate to the resolutions being considered. these questions will be responded to by the board during a meeting if appropriate. Questions should be submitted to [email protected] and include the shareholding name and address. Please refer to the full Notice of Meeting and Proxy Form for further important information. The Company thanks its shareholders for their continuing support. Your sincerely,
Damian Wright Joint Company Secretary 08 9390 6999 Level 1, 63-69 Abernethy Road, Belmont WA 6104 GenusPlus Group Ltd | ABN 86 620 283 561
1
GenusPlus Group Ltd ACN 620 283 561
Notice of Annual General Meeting
The Annual General Meeting of the Company will be held as follows: Time and date:
10.00am (AWST) on Friday, 20 November 2026
In-person:
Central Park, Level 43, 152 - 158 St Georges Terrace, Perth WA 6000
The Notice of Annual General Meeting should be read in its entirety. If Shareholders are in doubt as to how to vote, they should seek advice from their suitably qualified advisor prior to voting. Should you wish to discuss any matter, please do not hesitate to contact the Company on 08 9390 6999. Shareholders are urged to vote by lodging the Proxy Form
Page 1
GenusPlus Group Ltd ACN 620 283 561 (Company)
Notice of Annual General Meeting Notice is hereby given that the annual general meeting of Shareholders of GenusPlus Group Ltd ACN 620 283 561 (Company) will be held at Central Park, Level 43, 152 -158 St Georges Terrace, Perth WA 6000 on Friday, 20 November 2026 at 10.00am (AWST) (Meeting). The Explanatory Memorandum provides additional information on matters to be considered at the Meeting. The Explanatory Memorandum and the Proxy Form are included as part of the Notice. The Directors have determined pursuant to regulation 7.11.37 of the Corporations Regulations 2001 (Cth) that the persons eligible to vote at the Meeting are those who are registered as Shareholders on Wednesday, 18 November 2026 at 4.00pm (AWST). Terms and abbreviations used in the Notice are defined in Schedule 1.
Agenda 1
Annual Report To consider the Annual Report of the Company and its controlled entities for the financial year ended 30 June 2026, which includes the Financial Report, the Directors' Report and the Auditor's Report. Note: there is no requirement for Shareholders to approve the Annual Report.
2
Resolutions Resolution 1 – Remuneration Report To consider and, if thought fit, to pass with or without amendment, as a non-binding ordinary resolution the following: ‘That the Remuneration Report be adopted by Shareholders, on the terms and conditions in the Explanatory Memorandum.’ Note: a vote on this Resolution is advisory only and does not bind the Directors or the Company.
Resolution 2– Election of Director – Mr Antonio Narvaez To consider and, if thought fit, to pass with or without amendment, as an ordinary resolution the following:
Page 2
‘That Mr Antonio Narvaez, in accordance with Rule 6.1(e) of the Constitution, Listing Rule 14.4 and for all other purposes, retires and, being eligible and offering himself for election, is elected as a Director, on the terms and conditions in the Explanatory Memorandum.’
Resolution 3 – Election of Non-Board-Endorsed Director – Mr Stephen Mayne To consider and, if thought fit, to pass with or without amendment, as an ordinary resolution the following: 'That Mr Stephen Mayne, in accordance with Rule 6.1(m)(iii) of the Constitution and for all other purposes, being eligible and offering himself for election, is elected as a Director of the Company, on the terms and conditions in the Explanatory Memorandum.'
Resolution 4 – Increase in Non-Executive Directors' Fees To consider and, if thought fit, to pass with or without amendment, as an ordinary resolution the following: ‘That, pursuant to and in accordance with Rule 6.3(a) of the Constitution, Listing Rule 10.17 and for all other purposes, the total maximum aggregate Directors' fees payable to non-executive Directors be increased from $600,000 per annum to $850,000 per annum, on the terms and conditions in the Explanatory Memorandum.’
Resolution 5 – Approval of Employee Securities Incentive Plan To consider and, if thought fit, to pass with or without amendment, as an ordinary resolution the following: ‘That, pursuant to and in accordance with Listing Rule 7.2 (Exception 13(b)) and for all other purposes, Shareholders approve the employee incentive scheme of the Company known as the 'GenusPlus Group Ltd Employee Securities Incentive Plan' (ESIP) and the issue of up to a maximum number of 20,000,000 Equity Securities under the ESIP over a period of up to three years from the date of the Meeting, on the terms and conditions in the Explanatory Memorandum.’
Resolution 6 – Approval of Tax Exempt Plan To consider and, if thought fit, to pass with or without amendment, as an ordinary resolution the following: ‘That, pursuant to and in accordance with Listing Rule 7.2 (Exception 13(b)) and for all other purposes, Shareholders approve the employee incentive scheme of the Company known as the ‘GenusPlus Group Ltd Tax Exempt Share Plan’ (Tax Exempt Plan) and the issue of up to a maximum number of 20,000,000 Shares under the Tax Exempt Plan over a period of up to three years from the date of the Meeting, on the terms and conditions in the Explanatory Memorandum.’
Resolution 7– Renewal of Proportional Takeover Bid Approval Provisions
Page 3
To consider and, if thought fit, to pass with or without amendment, as a special resolution the following: 'That, for the purposes of sections 648G and 136(2) of the Corporations Act, Rule 14 of the Constitution and for all other purposes, approval is given for the Company to modify its Constitution to re-insert the approval of proportional takeover bid provisions contained in Rule 14 of the Constitution for a period of three years commencing from the date of approval of this Resolution, on the terms and conditions in the Explanatory Memorandum.'
Resolution 8 – Approval of Financial Assistance To consider and, if thought fit, to pass with or without amendment, as a special resolution the following: 'That, for the purposes of section 260B(2) of the Corporations Act, and for all other purposes, approval is given for the proposed financial assistance to be provided by each of the entities named below (which are or may become subsidiaries of the Company), as described in the Explanatory Memorandum provided to Shareholders, and other elements of the transactions there described that may constitute financial assistance for the purposes of section 260A of the Corporations Act, in connection with the acquisition of those entities (a)
MPC Kinetic Holdings Pty Ltd ACN 626 678 911 (MPC HoldCo);
(b)
MPC Kinetic Holdings (2) Pty Ltd ACN 626 679 258;
(c)
MPC Group Pty Ltd ACN 122 452 662;
(d)
MPC Group Holdings Pty Ltd ACN 620 867 398;
(e)
MPC Group Holdings (2) Pty Ltd ACN 620 876 495;
(f)
MPC Group Holdings (3) Pty Ltd ACN 142 862 904;
(g)
MPC Group Labour Pty Ltd ACN 168 268 344;
(h)
MPC Group Plant Pty Ltd ACN 129 658 126;
(i)
Kinetic Consolidated Pty Ltd ACN 154 343 343;
(j)
Kinetic Services Group Pty Ltd ACN 154 401 706;
(k)
Nortrus Pty Ltd ACN 127 959 264;
(l)
Kinetic Chemicals Pty Ltd ACN 010 867 759;
(m)
Kinetic Fluid Management and Production Services Pty Ltd ACN 160 811 987;
(n)
Kinetic Well Intervention Services Pty Ltd ACN 119 538 126;
(o)
Well Equipment Solutions Holdings Pty Ltd ACN 138 658 170; and
(p)
Well Equipment Solutions Pty Ltd ACN 138 658 456,
(together, MPC Group Entities); and
Page 4
(q)
Railtrain Holdings Pty Ltd ACN 626 189 464 (Railtrain HoldCo);
(r)
Railtrain Group Pty Ltd ACN 626 191 839;
(s)
RMC Rail Services Pty Ltd ACN 629 424 139;
(t)
RTS Rail Services Pty Ltd ACN 673 668 794;
(u)
Railtrain Pty Ltd ACN 145 155 666;
(v)
RMC Signalling and Electrical Pty Ltd ACN 626 193 333;
(w)
RMC Track and Civil Pty Ltd ACN 627 041 221;
(x)
RMC Track Protection Services Pty Ltd ACN 626 308 156;
(y)
McDonald Surveys International Pty Ltd ACN 154 048 110;
(z)
Wired Holding Company Pty Ltd ACN 639 942 733;
(aa)
Wired Overhead Solutions Pty Ltd ACN 611 975 298; and
(bb)
Railtrain Services Pty Ltd ACN 626 193 155,
(together, Railtrain Group Entities); and (cc)
Wanzeng Pty Ltd ACN 093 022 845 (Wanzeng),
of which the Company will be the listed Australian holding company to assist the acquisition by the Company of all of the issued shares in Wanzeng, MPC HoldCo and each of its subsidiaries, and Railtrain HoldCo and each of its subsidiaries (the Acquisitions).'
Resolution 9 – Ratification of prior issue of Placement Shares To consider and, if thought fit, to pass with or without amendment, as an ordinary resolution the following: 'That, in accordance with Listing Rule 7.4 and for all other purposes, Shareholders ratify the prior issue of 21,621,622 Shares (at an issue price of $9.25 per Share) issued under the Company's placement capacity under Listing Rule 7.1 to institutional and sophisticated investors on the terms and conditions in the Explanatory Memorandum.'
Voting prohibitions Resolution 1: In accordance with sections 250BD and 250R of the Corporations Act, a vote on this Resolution must not be cast (in any capacity) by or on behalf of a member of the Key Management Personnel details of whose remuneration are included in the Remuneration Report, or a Closely Related Party of such a member. A vote may be cast by such person if the vote is not cast on behalf of a person who is excluded from voting on this Resolution, and:
Page 5
(a)
the person is appointed as a proxy by writing that specifies the way the proxy is to vote on this Resolution; or
(b)
the voter is the Chair and the appointment of the Chair as proxy does not specify the way the proxy is to vote on this Resolution, but expressly authorises the Chair to exercise the proxy even if this Resolution is connected with the remuneration of a member of the Key Management Personnel.
Resolution 4, Resolution 5 and Resolution 6: In accordance with sections 250BD of the Corporations Act, a person appointed as a proxy must not vote, on the basis of that appointment, on the relevant Resolution if: (a)
the proxy is either a member of the Key Management Personnel or a Closely Related Party of such member; and
(b)
the appointment does not specify the way the proxy is to vote on the relevant Resolution.
However, the above prohibition does not apply if: (a)
the proxy is the Chair; and
(b)
the appointment expressly authorises the Chair to exercise the proxy even though the relevant Resolution is connected directly or indirectly with remuneration of a member of the Key Management Personnel.
Voting exclusions Pursuant to the Listing Rules, the Company will disregard any votes cast in favour of: Resolution 4: by or on behalf of a Director of the Company, or an Associate of that person or those persons. Resolution 5: by or on behalf of a person who is eligible to participate in the ESIP, or an Associate of that person or those persons. Resolution 6: by or on behalf of a person who is eligible to participate in the Tax Exempt Plan, or an Associate of that person or those persons. Resolution 9: by or on behalf of any person who participated in the issue of Shares or an Associate of that person or those persons. The above voting exclusions do not apply to a vote cast in favour of the relevant Resolution by: (a)
a person as a proxy or attorney for a person who is entitled to vote on the Resolution, in accordance with directions given to the proxy or attorney to vote on the Resolution in that way; or
(b)
the Chair as proxy or attorney for a person who is entitled to vote on the Resolution, in accordance with a direction given to the Chair to vote on the Resolution as the Chair decides; or
(c)
a holder acting solely in a nominee, trustee, custodial or other fiduciary capacity on behalf of a beneficiary provided the following conditions are met:
Page 6
(i)
the beneficiary provides written confirmation to the holder that the beneficiary is not excluded from voting, and is not an Associate of a person excluded from voting, on the Resolution; and
(ii)
the holder votes on the Resolution in accordance with directions given by the beneficiary to the holder to vote in that way.
BY ORDER OF THE BOARD Mr Damian Wright Joint Company Secretary GenusPlus Group Ltd Dated: 21 October 2026
Page 7
GenusPlus Group Ltd ACN 620 283 561 (Company)
Explanatory Memorandum 1.
Introduction The Explanatory Memorandum has been prepared for the information of Shareholders in connection with the business to be conducted at the Meeting to be held at Central Park, Level 43, 152 -158 St Georges Terrace, Perth WA 6000 on Friday, 20 November 2026 at 10.00am (AWST). The Explanatory Memorandum forms part of the Notice which should be read in its entirety. The Explanatory Memorandum contains the terms and conditions on which the Resolutions will be voted. The Explanatory Memorandum includes the following information to assist Shareholders in deciding how to vote on the Resolutions: Section 2
Action to be taken by Shareholders
Section 3
Annual Report
Section 4
Resolution 1 – Remuneration Report
Section 5
Resolution 2 – Election of Director – Mr Antonio Narvaez
Section 6
Resolution 3 – Election of Non-Board-Endorsed Director – Mr Stephen Mayne
Section 7
Resolution 4 – Increase in Non-Executive Directors' Fees
Section 8
Resolution 5 – Approval of Employee Securities Incentive Plan and Resolution 6 – Approval of Tax Exempt Plan
Section 9
Resolution 7 – Renewal of Proportional Takeover Bid Approval Provisions
Section 10
Resolution 8 – Approval of Financial Assistance
Section 11
Resolution 9 – Ratification of prior issue of Placement Shares
Schedule 1
Definitions
A Proxy Form is located at the end of the Explanatory Memorandum.
Page 8
Action to be taken by Shareholders Shareholders should read the Notice including the Explanatory Memorandum carefully before deciding how to vote on the Resolutions. Voting on all proposed Resolutions at the Meeting will be conducted by poll. On a poll, each Shareholder has one vote for every fully paid ordinary Share held in the Company.
2.1
Voting in person To vote in person, attend the Meeting on the date and at the place set out above.
2.2
Voting by a corporation A Shareholder that is a corporation may appoint an individual to act as its representative and vote in person at the Meeting. The appointment must comply with the requirements of section 250D of the Corporations Act. The representative should bring to the Meeting evidence of his or her appointment, including any authority under which it is signed.
2.3
Voting by proxy Shareholders are encouraged to vote by completing a Proxy Form. A Proxy Form is attached to the Notice. This is to be used by Shareholders if they wish to appoint a representative (a ‘proxy’) to vote in their place. All Shareholders are invited and encouraged to attend the Meeting or, if they are unable to attend in person, sign and return the Proxy Form to the Company in accordance with the instructions thereon. Lodgement of a Proxy Form will not preclude a Shareholder from attending and voting at the Meeting in person. Please note that: (a)
a member of the Company entitled to attend and vote at the Meeting is entitled to appoint a proxy;
(b)
a proxy need not be a member of the Company; and
(c)
a member of the Company entitled to cast two or more votes may appoint two proxies and may specify the proportion or number of votes each proxy is appointed to exercise, but where the proportion or number is not specified, each proxy may exercise half of the votes.
The enclosed Proxy Form provides further details on appointing proxies and lodging Proxy Forms. Section 250BB(1) of the Corporations Act provides that an appointment of a proxy may specify the way the proxy is to vote on a particular resolution and, if it does: (a)
the proxy need not vote on a show of hands, but if the proxy does so, the proxy must vote that way (i.e. as directed);
(b)
if the proxy has 2 or more appointments that specify different ways to vote on the resolution – the proxy must not vote on a show of hands;
(c)
if the proxy is the Chair of the meeting at which the resolution is voted on – the proxy
Page 9
must vote on a poll, and must vote that way (i.e. as directed); and (d)
if the proxy is not the Chair – the proxy need not vote on the poll, but if the proxy does so, the proxy must vote that way (i.e. as directed).
Section 250BC of the Corporations Act provides that, if: (a)
an appointment of a proxy specifies the way the proxy is to vote on a particular resolution at a meeting of the Company’s members;
(b)
the appointed proxy is not the chair of the meeting;
(c)
at the meeting, a poll is duly demanded, or is otherwise required under section 250JA on the resolution; and
(d)
either the proxy is not recorded as attending the meeting or the proxy does not vote on the resolution,
the Chair of the meeting is taken, before voting on the resolution closes, to have been appointed as the proxy for the purposes of voting on the resolution at the meeting. Your proxy voting instruction must be received by 10.00am (AWST) on Wednesday, 18 November 2026, being not later than 48 hours before the commencement of the Meeting. 2.4
Chair’s voting intentions If the Chair is your proxy, either by appointment or by default, and you have not indicated your voting intention, you expressly authorise the Chair to exercise the proxy in respect of Resolutions 1, 4, 5 and 6, even though these Resolutions are connected directly or indirectly with the remuneration of the Company’s Key Management Personnel. The Chair intends to exercise all available proxies in favour of all Resolutions (except Resolution 3 in respect of which the Chair intends to exercise all available proxies against that Resolution), unless the Shareholder has expressly indicated a different voting intention.
2.5
Submitting questions Shareholders may submit questions in advance of the Meeting to the Company. Questions must be submitted by emailing the Company Secretary at [email protected] by no later than 5.00pm (AWST) on Friday, 13 November 2026. Shareholders will also have the opportunity to submit questions during the Meeting in respect of the formal items of business. In order to ask a question during the Meeting, please follow the instructions from the Chair. The Chair will attempt to respond to the questions during the Meeting. The Chair will request prior to a Shareholder asking a question that they identify themselves (including the entity name of their shareholding and the number of Shares they hold).
Annual Report In accordance with section 317 of the Corporations Act, Shareholders will be offered the opportunity to discuss the Annual Report, including the Financial Report, the Directors’ Report and the Auditor’s Report for the financial year ended 30 June 2026.
Page 10
There is no requirement for Shareholders to approve the Annual Report. At the Meeting, Shareholders will be offered the opportunity to: (a)
discuss the Annual Report which is available online at www.genus.com.au/investorrelations/asx-announcements;
(b)
ask questions about, or comment on, the management of the Company; and
(c)
ask the auditor questions about the conduct of the audit and the preparation and content of the Auditor’s Report.
In addition to taking questions at the Meeting, written questions to the Chair about the management of the Company, or to the Company’s auditor about: (a)
the preparation and content of the Auditor’s Report;
(b)
the conduct of the audit;
(c)
accounting policies adopted by the Company in relation to the preparation of the financial statements; and
(d)
the independence of the auditor in relation to the conduct of the audit,
may be submitted no later than five business days before the Meeting to the Company Secretary at the Company’s registered office. The Company will not provide a hard copy of the Company’s Annual Report to Shareholders unless specifically requested to do so.
Resolution 1 – Remuneration Report
4.1
General In accordance with section 250R(2) of the Corporations Act, the Company must put the Remuneration Report to the vote of Shareholders. The Directors’ Report for the year ended 30 June 2026 in the Annual Report contains the Remuneration Report which sets out the remuneration policy for the Company and the remuneration arrangements in place for specified executives and non-executive Directors. In accordance with section 250R(3) of the Corporations Act, Resolution 1 is advisory only and does not bind the Directors. If Resolution 1 is not passed, the Directors will not be required to alter any of the arrangements in the Remuneration Report. If the Company’s Remuneration Report receives a ‘no’ vote of 25% or more (Strike) at two consecutive annual general meetings, Shareholders will have the opportunity to remove the whole Board, except the managing director (if any). Where a resolution on the Remuneration Report receives a Strike at two consecutive annual general meetings, the Company will be required to put to Shareholders at the second annual general meeting a resolution on whether another meeting should be held (within 90 days) at which all Directors (other than the managing director, if any) who were in office at the date of approval of the applicable Directors’ Report must stand for re-election.
Page 11
The Company’s Remuneration Report did not receive a Strike at the 2025 annual general meeting held on 20 November 2025. If the Remuneration Report receives a Strike at this Meeting, Shareholders should be aware that if a second Strike is received at the 2027 annual general meeting, this may result in the re-election of the Board. The Chair will allow a reasonable opportunity for Shareholders as a whole to ask about or make comments on the Remuneration Report. Resolution 1 is an ordinary resolution. 4.2
Directors' recommendation Given the personal interests of all Directors in the outcome of this Resolution, the Board declines to make a recommendation to Shareholders regarding this Resolution.
Resolution 2 – Election of Director – Mr Antonio Narvaez
5.1
Background Rule 6.1(d) of the Constitution provides that the Directors may appoint any natural person to be a director, either as an addition to the existing Directors or to fill a casual vacancy. Mr Antonio Narvaez was appointed as a Director by the Board on 21 November 2025 in accordance with Rule 6.1(d). Rule 6.1(e) of the Constitution provides that a director appointed under Rule 6.1(d) must retire from office at the next annual general meeting following his or her appointment. Accordingly, Mr Narvaez retires under Rule 6.1(e) of the Constitution and, being eligible, seeks election at the Meeting pursuant to this Resolution 2. If Resolution 2 is passed, Mr Narvaez will be elected as a Director of the Company with effect from the conclusion of the Meeting. If Resolution 2 is not passed, Mr Narvaez will not be elected as a Director of the Company. Resolution 2 is an ordinary resolution.
5.2
Biography – Mr Antonio Narvaez Mr Narvaez has extensive energy sector experience, having held CEO roles at AusNet Services (previously listed ASX100 company), Endeavour Energy, United Energy and Multinet Gas, as well as executive positions at General Electric and Verve Energy. Mr Narvaez has a deep understanding of distribution and transmission networks, along with renewable and thermal generation developments domestically and abroad. He has also had significant board experience as the Managing Director of AusNet Services and in his roles as chair to several AusNet Services subsidiaries and as a director on a number of joint venture boards. Mr Narvaez currently serves as a Non-Executive Director of GreenSquareDC, a private equity owned data centre provider in Australia. Mr Narvaez holds a Bachelor’s degree in Commerce & Economics, a Diploma in Financial Services and has completed executive studies at Harvard Business School.
5.3
Directors’ recommendation The Board has reviewed Mr Narvaez's performance since his appointment to the Board and considers that his skills and experience will continue to enhance the Board’s ability to perform its role. The Board (with Mr Narvaez abstaining) supports the election of Mr Narvaez and recommends
Page 12
that Shareholders vote in favour of Resolution 2.
Resolution 3 – Election of Non-Board-Endorsed Director
6.1
Background Under Rule 6.1 of the Constitution, a person may be elected as a Director at a general meeting if a notice of nomination (signed by the person) is served on the Company at its registered office at least 35 business days before the Meeting or a shorter period before the Meeting which the Directors in their discretion may approve. Pursuant to an ASX announcement dated 16 September 2026, the Directors determined that the closing date for the receipt of nominations from persons wishing to be considered for election as a director of the Company was 13 October 2026. Mr Stephen Mayne, an external non-Board-endorsed candidate, being eligible, has nominated himself for appointment to the Board of the Company. If Resolution 3 is passed, Mr Mayne will be elected as a Director of the Company with effect from the conclusion of the Meeting. If Resolution 3 is not passed, Mr Mayne will not be elected as a Director of the Company. Resolution 3 is an ordinary resolution.
6.2
Biography – Mr Stephen Mayne The following information was provided by Mr Stephen Mayne and has not been independently verified by the Company, nor does the Company make any representation as to its accuracy: 'Stephen Mayne, 57. BCom (Melb). GAICD. Stephen is a Walkley Award-winning business journalist and Australia’s best known retail shareholder advocate. He was the founder of www.crikey.com.au, publishes the corporate governance website www.maynereport.com, writes regular columns for The Intelligent Investor and co-hosts The Money Café podcast with Alan Kohler. His governance experience includes 8 years as a City of Manningham councillor in Melbourne’s eastern suburbs, a 4 year term (2012-2016) as a City of Melbourne councillor where he chaired the Finance and Governance committee, almost 5 years on the Australian Shareholders’ Association board and asking questions at more than 1400 ASX-listed company AGMs and EGMs since 1998. Stephen nominated for the GenusPlus Group board out of concern that it has once again chosen to run a physical AGM in Perth, the world’s most isolated major city, which makes it very difficult for interstate and offshore shareholders to participate. GenusPlus Group, which was is capitalised at $1.96 billion on September 25 and has thousands of shareholders, should be offering hybrid AGMs with both a physical location and the ability for shareholders to vote and ask questions live online during proceedings. Stephen is also concerned that the GenusPlus board has a history of doing big end of town placements without offering its retail shareholders a chance to participate on the same terms through a Share Purchase Plan (SPP), as occurred with the $200m placement at $9.25 per share in May 2026. Offering SPPs after placements should be standard practice but the culture amongst many Perth-based companies is to prioritise the clients of the brokers handling the placement, whilst ignoring retail shareholders, who don’t pay commissions to brokers. A vote for Stephen will send a message to the board to include retail shareholders in the company’s next capital raising and send a message to the wider market about the need for better treatment of retail shareholders in capital raisings. Contact Stephen by
Page 13
email at [email protected] or via www.maynereport.com.' 6.3
Directors' recommendation Board succession planning and director appointments are an ongoing responsibility of the Board and the Board periodically reviews its current and future needs and how those align with the skills and experience currently represented among the Directors. The Company's Remuneration and Nomination Committee (Committee) is responsible for, amongst other things, reviewing and implementing the Company's procedures for the selection and appointment of new directors and making nomination recommendations to the Board. In considering new director appointments, the Committee's usual practice is to conduct a search for the best available candidates with the skills, experience, expertise, personal qualities and attributes to best complement the skill set and characteristics of the existing directors and enhance the Board's overall effectiveness. The Committee also considers the current diversity of the Board, including age, gender, cultural background, as well as the composition and size of the Board when determining whether a candidate will add value to the Board. Having regard to the Company's skill matrix, current Board composition and the skills and experience of Mr Mayne, the Directors have formed the view that Mr Mayne does not offer relevant skills or the experience required at this time to endorse his nomination as a Director of the Company. The Board does not support the election of Mr Mayne and recommends that Shareholders vote against Resolution 3.
Resolution 4 – Increase in Non-Executive Directors' Fees
7.1
Background Resolution 4 seeks Shareholder approval for the purposes of Rule 6.3(a) of the Constitution, Listing Rule 10.17 and for all other purposes, for the Company to be authorised to increase the maximum total aggregate amount of fees payable to its non-executive Directors from $600,000 per annum to an aggregate amount of $850,000 per annum. It is not intended to fully utilise the increased aggregate fees in the immediate future. However the Company wishes to provide sufficient flexibility to do so without the need to hold a further general meeting. The Company has grown significantly since the Company last increased the Non-Executive Directors' Fees at the 2024 annual general meeting and the demands on its Board have increased commensurately. The Board considers that it is reasonable and appropriate at this time to seek an increase in the remuneration pool for non-executive Directors so as to provide flexibility to increase the number of non-executive directors, should the Board consider that necessary in order to meet its increasing governance and oversight responsibilities. The maximum aggregate fees payable to non-executive Directors were last increased at the Company's 2024 annual general meeting. If Resolution 4 is passed, the maximum aggregate amount of fees that may be paid to all of the Company’s non-executive Directors will be $850,000 per annum. This does not mean that the Company must utilise the entire maximum amount approved for non-executive Directors’ fees in each year. However, the Board considers that it is reasonable and appropriate to establish this amount to provide the Company with the ability to pay non-executive Directors and ensure their remuneration levels are commensurate with market rates to attract and retain Directors of the highest calibre.
Page 14
If Resolution 4 is not passed, the Company will not be permitted to pay fees to its non-executive Directors which exceed the aggregate amount of directors’ fees already approved by Shareholders as set out in this Notice (that is, $600,000 per annum). Resolution 4 is an ordinary resolution. The remuneration of each non-executive Director for the financial year ended 30 June 2026 is detailed in the Remuneration Report in the Company's Annual Report. 7.2
Specific information required under Listing Rule 10.17 The Company provides the following information as required under Listing Rule 10.17:
7.3
(a)
the amount of the proposed increase is $250,000 per annum;
(b)
the maximum aggregate amount of non-executive Directors' fees if this Resolution is passed will be $850,000 per annum;
(c)
no Equity Securities have been issued to non-executive Directors under Listing Rule 10.11 or Listing Rule 10.14 in the past 3 years; and
(d)
a voting exclusion statement is included in the Notice.
Directors' recommendation Given the personal interests of Directors in the outcome of this Resolution, the Board declines to make a recommendation to Shareholders regarding this Resolution.
Resolution 5 & Resolution 6 – Approval of ESIP and Tax Exempt Plan
8.1
General Resolution 5 and Resolution 6 seek Shareholder approval of the ESIP and the Tax Exempt Plan and the issue of: (a)
Equity Securities under the ESIP; and
(b)
Shares under the Tax Exempt Plan,
pursuant to Listing Rule 7.2 (Exception 13(b)) and as an exception to Listing Rule 7.1 for a period of three years from the date on which Resolution 5 and Resolution 6 (respectively) are approved. Shareholder approval of the ESIP and the Tax Exempt Plan is required to ensure that securities granted or issued under each plan are not counted in the Company's 15% annual limit on issuing securities without Shareholder approval under Listing Rule 7.1 (please see further explanation below). Both the ESIP and the Tax Exempt Plan were adopted and approved by Shareholders at the Company's 2023 annual general meeting held on 24 November 2023. This approval was for a period of three years from the date of the 2023 annual general meeting and will expire on 24 November 2026. Accordingly, Shareholder approval is required to allow the Company to continue to rely on the exception in Listing Rule 7.2 (Exception 13(b)) for a further three year period. There have been no material changes to the ESIP nor the Tax Exempt Plan since each plan was approved by Shareholders in 2023.
Page 15
The Board may offer to eligible persons the opportunity to subscribe for such number of Equity Securities in the Company as the Board may decide and on the terms set out in the rules of each plan. A summary of the material terms of the ESIP is set out in Schedule 2 and a summary of the material terms of the Tax Exempt Plan is set out in Schedule 3. In addition, copies of the ESIP and the Tax Exempt Plan are available for review by Shareholders at the registered office of the Company until the date of the Meeting. The purpose of the ESIP and the Tax Exempt Plan is to: (a)
assist in the reward, retention and motivation of eligible participants;
(b)
link the reward of eligible participants to Shareholder value creation; and
(c)
align the interests of eligible participants with shareholders of the Group (being the Company and each of its subsidiaries), by providing an opportunity to eligible participants to receive an equity interest in the Company in the form of Equity Securities.
Shareholders are invited to contact the Company if they have any queries. 8.2
Listing Rules 7.1 and 7.2 (Exception 13(b)) Broadly speaking, and subject to a number of exceptions, Listing Rule 7.1 limits the amount of Equity Securities that a listed company can issue without the approval of its shareholders over any 12-month period to 15% of the fully paid ordinary securities it had on issue at the start of that period. Listing Rule 7.2 (Exception 13(b)) provides an exception to Listing Rule 7.1 such that issues of Equity Securities under an employee incentive scheme are exempt for a period of three years from the date on which Shareholders approve the issue of Equity Securities under the scheme as an exception to Listing Rule 7.1. Listing Rule 7.2 (Exception 13(b)) is only available if and to the extent that the number of Equity Securities issued under the ESIP or the Tax Exempt Plan does not exceed the maximum number set out in this Notice. Further, Listing Rule 7.2 (Exception 13(b)) ceases to be available to the Company: (a)
in respect of the ESIP, if there is a material change to the terms of the ESIP from those set out in this Notice in Schedule 2; and
(b)
in respect of the Tax Exempt Plan, if there is a material change to the terms of the Tax Exempt Plan from those set out in this Notice in Schedule 3.
If Resolution 5 is passed, the Company will be able to issue Equity Securities under the ESIP pursuant to Listing Rule 7.2 (Exception 13(b)) to eligible participants over a period of three years up to the nominated maximum amount without using the Company’s 15% placement capacity under Listing Rule 7.1. If Resolution 6 is passed, the Company will be able to issue Shares under the Tax Exempt Plan pursuant to Listing Rule 7.2 (Exception 13(b)) to eligible participants over a period of three years up to the nominated maximum amount without using the Company’s 15% annual placement capacity under Listing Rule 7.1. However, any future issues of Equity Securities under the ESIP or the Tax Exempt Plan to a related party or a person whose relationship with the Company or the related party is, in ASX’s opinion, such that approval should be obtained will require additional Shareholder approval under Listing Rule 10.14 at the relevant time.
Page 16
If Resolution 5 is not passed, any issue of Equity Securities pursuant to the ESIP must be undertaken using the Company’s 15% placement capacity under Listing Rule 7.1 (thereby reducing the Company's capacity to issue Equity Securities without Shareholder approval under Listing Rule 7.1 for the 12-month period following the issue) or with prior Shareholder approval. If Resolution 6 is not passed, any issue of Shares pursuant to the Tax Exempt Plan must be undertaken using the Company’s 15% placement capacity under Listing Rule 7.1 (thereby reducing the Company's capacity to issue Equity Securities without Shareholder approval under Listing Rule 7.1 for the 12-month period following the issue) or with prior Shareholder approval. Resolution 5 and Resolution 6 are separate ordinary resolutions. 8.3
Specific information required by Listing Rule 7.2 (Exception 13(b)) The Company provides the following information as required under Listing Rule 7.2 (Exception 13(b)): (a)
A summary of the material terms of the ESIP is set out in Schedule 2 and a summary of the material terms of the Tax Exempt Plan is set out in Schedule 3.
(b)
The Company last approved the ESIP and the Tax Exempt Plan on 24 November 2023 and since that time, the Company has issued: (i)
4,445,667 Equity Securities to eligible participants under the ESIP; and
(ii)
62,240 Equity Securities to eligible participants under the Tax Exempt Plan.
(c)
The maximum number of Equity Securities that the Company proposes to issue under the ESIP is 20,000,000, subject to Shareholder approval of Resolution 5. This number comprises approximately 10% of the Company's Equity Securities currently on issue.
(d)
The maximum number of Shares that the Company proposes to issue under the Tax Exempt Plan is 20,000,000, subject to Shareholder approval of Resolution 6. This number comprises approximately 10% of the Company's Equity Securities currently on issue. It should be noted that these figures are not an indication of the actual number of equity securities that may be issued under the ESIP or the Tax Exempt Plan; rather, they are a “ceiling” for the purposes of ASX Listing Rule 7.2 (Exception 13(b)).
(e) 8.4
A voting exclusion statement in respect of Resolution 5 and Resolution 6 is included in the Notice.
Directors' recommendation The Board declines to make a recommendation in relation to Resolution 5 and Resolution 6 due to the Directors' potential interests in the outcome of the Resolutions.
Resolution 7– Renewal of Proportional Takeover Bid Approval Provisions
9.1
General The Company's Constitution (Rule 14) contains proportional takeover bid approval provisions (Proportional Takeover Provisions) which enable the Company to refuse to register securities acquired under a proportional takeover bid unless a resolution is passed by Shareholders in general meeting approving the offer. Under the Corporations Act, proportional takeover provisions expire after three years from adoption or re-insertion and may then be re-inserted.
Page 17
The Company obtained Shareholder approval at its 2023 annual general meeting for the reinsertion of the Proportional Takeover Provisions, which will expire on 24 November 2026. Accordingly, Resolution 7 seeks the approval of Shareholders to modify the Constitution by reinserting the Proportional Takeover Provisions for a further three years under sections 648G(4) and 136(2) of the Corporations Act. The proposed Proportional Takeover Provisions set out in Schedule 4 are identical to those previously contained at Rule 14 of the Constitution. The Corporations Act requires the Company to provide Shareholders with an explanation of the Proportional Takeover Provisions as set out below. 9.2
Specific information required by section 648G of the Corporations Act (a)
Effect of Proportional Takeover Provisions to be renewed A proportional off-market takeover bid (PT Bid) is a takeover offer sent to all Shareholders but only for a specified portion of each Shareholder's Securities. Where offers have been made under a PT Bid in respect of a class of securities in a company, the registration of a transfer giving effect to a contract resulting from the acceptance of an offer made under such a PT Bid is prohibited unless and until a resolution to approve the PT Bid is passed.
(b)
Reasons for renewing Proportional Takeover Provisions If the Proportional Takeover Provisions are re-inserted, under Rule 14 of the Constitution if a PT Bid is made to Shareholders of the Company, the Board is required to convene a meeting of Shareholders to vote on a resolution to approve the proportional takeover. That meeting must be held at least 15 days before the offer under the PT Bid closes. The resolution is taken to have been passed if a majority of Securities voted at the meeting, excluding the Securities of the bidder and its associates, vote in favour of the resolution. If no resolution is voted on at least 15 days before the close of the PT Bid, the resolution is deemed to have been passed. Where the resolution approving the PT Bid is passed or deemed to have been passed, transfers of Securities resulting from accepting the PT Bid are registered provided they otherwise comply with the Corporations Act, the Listing Rules, the ASX Operating Rules and the Company's Constitution. If the resolution is rejected, then under the Corporations Act the PT Bid is deemed to be withdrawn. The Directors consider that Shareholders should have the opportunity to renew the Proportional Takeover Provisions. Without the Proportional Takeover Provisions applying, a PT Bid for the Company may enable effective control of the Company to be acquired without Shareholders having the opportunity to dispose of all of their Securities to the bidder. Shareholders could be at risk of passing control to the bidder without payment of an adequate control premium for all their Securities whilst leaving themselves as part of a minority interest in the Company. Without the Proportional Takeover Provisions, if there was a PT Bid and Shareholders considered that control of the Company was likely to pass, Shareholders would be placed under pressure to accept the PT Bid even if they did not want control of the Company to pass to the bidder. Renewing the Proportional Takeover Provisions will make this situation less likely by permitting Shareholders to decide whether a PT Bid should be permitted to proceed.
(c)
Knowledge of any acquisition proposals As at the date of this Notice, no Director is aware of any proposal by any person to acquire, or to increase the extent of, a substantial interest in the Company.
Page 18
(d)
Advantages and disadvantages of the Proportional Takeover Provisions since last renewal As there have been no takeover bids made for any of the shares in the Company since the Proportional Takeover Provisions were last renewed, there has been no application of the provisions. It may be argued that the potential advantages and disadvantages described below have also applied for the period since adoption of Proportional Takeover Provisions.
(e)
Potential advantages and disadvantages of Proportional Takeover Provisions The renewal of the Proportional Takeover Provisions will enable the Directors to formally ascertain the views of Shareholders about a PT Bid. Without these provisions, the Directors are dependent upon their perception of the interests and views of Shareholders. Other than this advantage, the Directors consider that renewal of the Proportional Takeover Provisions has no potential advantages or potential disadvantages for them, as they remain free to make a recommendation on whether a PT Bid should be accepted. The Directors consider that re-inserting the Proportional Takeover Provisions benefits all Shareholders in that they will have an opportunity to consider a PT Bid and then attend or be represented by proxy at a meeting of Shareholders called specifically to vote on the proposal. Accordingly, Shareholders are able to prevent a PT Bid proceeding if there is sufficient support for the proposition that control of the Company should not be permitted to pass under the PT Bid. Furthermore, knowing the view of Shareholders assists each individual Shareholder to assess the likely outcome of the PT Bid and whether to accept or reject that bid. As to the possible disadvantages to Shareholders renewing the Proportional Takeover Provisions, potentially, the proposal makes a PT Bid more difficult and PT Bids will therefore be discouraged. This may reduce the opportunities which Shareholders may have to sell all or some of their Securities at a premium to persons seeking control of the Company and may reduce any takeover speculation element in the Company's Share price. The Proportional Takeover Provisions may also be considered an additional restriction on the ability of individual Shareholders to deal freely in their Securities. The Directors consider that there are no other advantages or disadvantages for Directors or Shareholders which arose during the period during which the Proportional Takeover Provisions were in effect, other than those discussed in this Section.
(f)
Recommendation of the Board The Directors do not believe the potential disadvantages outweigh the potential advantages of renewing the Proportional Takeover Provisions and as a result consider that the Proportional Takeover Provisions in the Constitution are in the best interests of Shareholders and unanimously recommend that Shareholders vote in favour of Resolution 7.
9.3
Additional information Resolution 7 is a special resolution and therefore requires approval of at least 75% of the votes cast by Shareholders present and eligible to vote (in person, by proxy, by attorney or, in the case
Page 19
of a corporate Shareholder, by a corporate representative). 9.4
Directors' recommendation The Board recommends that Shareholders vote in favour of Resolution 7.
Resolution 8 – Approval of Financial Assistance
10.1
Proposed resolution Resolution 8 seeks the approval of Shareholders, under section 260B(2) of the Corporations Act, for financial assistance which is proposed to be provided by each of Wanzeng, the MPC Group Entities and the Railtrain Group Entities to assist the acquisition by the Company of all of the issued shares in each of Wanzeng, MPC HoldCo and each of its subsidiaries, and Railtrain HoldCo and each of its subsidiaries (New Subsidiaries).
10.2
Background (a)
On 8 May 2026, the Company acquired all of the issued shares in Wanzeng.
(b)
On 1 April 2026, the Company acquired all of the issued shares in Railtrain HoldCo and each of its subsidiaries.
(c)
On 1 July 2026, the Company acquired all of the issued shares in MPC HoldCo and each of its subsidiaries.
(d)
On completion of the Acquisitions, the Company became the listed Australian holding company of each of the New Subsidiaries.
(e)
In order to fund part of the consideration for the Acquisitions, the Company utilised existing debt facilities available under the syndicated facility agreement dated 19 December 2025 (as amended on 20 April 2026 and as further amended on 17 May 2026) between, among others, the Company, CBA Corporate Services (NSW) Pty Ltd ACN 072 765 434 as security trustee for the GenusPlus Syndicated Security Trust (Security Trustee) and Commonwealth Bank of Australia ABN 48 123 123 124 (Agent) (Facility Agreement). Under the Facility Agreement, the Original Lenders (as defined in the Facility Agreement) agree to provide financial accommodation (the Facilities) to the Company to fund, among other things, permitted acquisitions and the general corporate and working capital requirements of the Group from time to time.
(f)
The Company and certain of its subsidiaries guarantee the Facilities and grant security over all of their assets in favour of the Security Trustee to secure the Facilities. The Security Trustee holds that security on trust for the Original Lenders under a security trust deed dated 19 December 2025 between, among others, the Company, the Agent and the Security Trustee (Security Trust Deed).
(g)
Under the terms of the Facility Agreement, the Company is required to ensure that each of the New Subsidiaries accedes as an ‘Additional Guarantor’ (as defined in the Facility Agreement) to the Facility Agreement and the Security Trust Deed, which will require each of the New Subsidiaries to provide, among other things, in accordance with the Facility Agreement: (i)
an accession letter for the purposes of the Facility Agreement and an accession deed for the purposes of the Security Trust Deed;
Page 20
(h)
(i)
10.3
10.4
(ii)
a guarantee and indemnity in favour of the Original Lenders to guarantee all amounts (Guaranteed Money) owing under or in relation to the Facilities (Guarantee); and
(iii)
a general security deed in favour of the Security Trustee as specified by the Agent giving security over all or substantially all of its assets which may be the subject of a security interest by law (GSD).
In addition to executing the Guarantee, each of the New Subsidiaries may, or may be required to: (i)
execute, or accede or consent to, any instrument referred to in, or incidental or related to, the “Finance Documents” (as defined in the Facility Agreement) (Finance Documents); or
(ii)
provide additional support (which may include incurring additional obligations, giving new guarantees or new security interests) in connection with the Finance Documents.
Execution by each of the New Subsidiaries of the Guarantee and GSD, and entry into any of the other transactions listed or contemplated in paragraph (h) above (together, the Financial Assistance) will have the effect of each of the New Subsidiaries financially assisting in the acquisition of its own shares or the shares in a holding company of it for the purposes of the Corporations Act.
Corporations Act requirements (a)
Under section 260A(1) of the Corporations Act, a company may financially assist a person to acquire shares in it or its holding company only in certain limited circumstances, including where the assistance is approved by shareholders under section 260B of the Corporations Act.
(b)
Under section 260B(1) of the Corporations Act, shareholder approval must be given by the shareholders of the company at a general meeting by either: (i)
a special resolution, with no votes being cast in favour of the resolution by the person acquiring the shares (or units of shares) or by their associates; or
(ii)
a resolution agreed to, at a general meeting, by all ordinary shareholders.
(c)
The giving of the Financial Assistance has been, or will be, approved by a unanimous resolution of the shareholders of each of the New Subsidiaries in accordance with section 260B(1) of the Corporations Act.
(d)
In addition, as each of the New Subsidiaries became a subsidiary of a listed Australian holding corporation (the Company) immediately after the Acquisitions, the Financial Assistance must also be approved by a special resolution passed at a general meeting of the Company under section 260B(2) of the Corporations Act. Accordingly, it is proposed that the Financial Assistance now be approved by special resolution of the Shareholders.
Effect of the Financial Assistance (a)
The Company is already itself liable for amounts payable under the Finance Documents and has provided security over its assets to secure the amounts due under the Finance
Page 21
Documents, so the giving of the Financial Assistance is unlikely to adversely affect the Company or each of the New Subsidiaries, except that each of the New Subsidiaries will become bound by the Finance Documents, will assume joint and several liability with the Company and each other guarantor for the Guaranteed Money and the operations of each of the New Subsidiaries will be restricted by the representations and undertakings given by it under the Finance Documents. (b)
The Guarantee to be given by each of the New Subsidiaries will be on the same terms as the Guarantee already given by the Company to secure the Guaranteed Money.
(c)
The substantial effect of the Financial Assistance on each of the New Subsidiaries will be that each of the New Subsidiaries will guarantee the amounts payable under the Finance Documents and grant a security interest in all of their assets and undertaking, present and future, to secure the guarantee.
(d)
The principal advantage to the Company (and, indirectly, each of the New Subsidiaries) is to ensure that the Group continues to have the benefit of the Facilities and comply with their obligations under the Facility Agreement.
(e)
Other advantages to each of the New Subsidiaries include that it:
(f)
(g)
10.5
(i)
may benefit from the working capital and general corporate facilities and other facilities provided under the Facility Agreement;
(ii)
may benefit from assisting the Company to raise money in order to later provide its subsidiaries with finance on better terms than would otherwise have been available to each of the New Subsidiaries on a stand-alone basis; and
(iii)
will be able to draw on the capital resources and management expertise of the Group.
The disadvantages of the Financial Assistance for each of the New Subsidiaries include that: (i)
will become liable for all amounts outstanding under the Finance Documents;
(ii)
if an event of default were to occur under the Facility Agreement, the Original Lenders may require immediate repayment of all amounts outstanding under the Finance Documents and enforce the Guarantee and GSD granted by each of the New Subsidiaries to recover amounts due which may ultimately result in the loss of the New Subsidiaries' assets or a winding up; and
(iii)
its operations and ability to independently obtain finance from other sources may be restricted by the undertakings, representations and warranties given under the Finance Documents.
The Board have considered the giving of the Financial Assistance and are of the opinion that there are reasonable grounds to believe that it is in the best interests and for the commercial benefit of the Company and each of the New Subsidiaries.
Additional information Resolution 8 is a special resolution and requires approval of at least 75% of the votes cast by Shareholders present and eligible to vote (in person, by proxy, by attorney or, in the case of a corporate Shareholder, by a corporate representative). Resolution 8 will be passed if at least
Page 22
75% of the votes cast by Shareholders, who are entitled to vote, vote in favour of the resolution. Shareholders may vote either for or against Resolution 8. Shareholders have been informed of the above matters in accordance with section 260B(4) of the Corporations Act. The Board considers that this Explanatory Memorandum contains all information known to the Company that is material to the Shareholders' decision on how to vote on Resolution 8, other than information it would be unreasonable to include because it had previously been disclosed to the Shareholders. 10.6
Directors' unanimous recommendation The Board unanimously recommends that Shareholders vote in favour of Resolution 8.
10.7
Notice to ASIC As required by sections 260B(5) and 249A(5) of the Corporations Act, copies of the proposed resolution and the documents relating to the Financial Assistance that accompanied the resolution sent to the Shareholders (including this Explanatory Memorandum), were lodged with the Australian Securities and Investments Commission before being sent to the Shareholders.
Resolution 9 – Ratification of prior issue of Placement Shares
11.1
General On 18 May 2026, the Company announced that it had entered into a share purchase agreement to acquire 100% of the issued capital in MPC Kinetic Holdings Pty Ltd (MPK) for total consideration of $400 million. MPK is a leading provider of gas gathering and well maintenance services to Tier 1 customers in the Queensland onshore gas sector, as well as construction services for renewable energy and major pipeline projects in Australia. On 20 May 2026, the Company announced a placement of 21,621,622 Shares at an issue price of $9.25 per Share (Placement Shares) to institutional and sophisticated investors to raise total funds of approximately $200 million (before costs) (Placement). The purpose of the Placement was to partially fund the strategic acquisition of MPK. The Placement Shares were issued on 25 May 2026. The Placement was undertaken using the Company's 15% placement capacity under Listing Rule 7.1.
11.2
Listing Rules 7.1 and 7.4 As noted above in Section 8.2, generally, Listing Rule 7.1 limits the amount of Equity Securities that a listed company can issue without the approval of its shareholders over any 12-month period to 15% of the fully paid ordinary securities it had on issue at the start of that period. There are a number of exceptions to Listing Rule 7.1. The issue of the Placement Shares does not fit within any of the exceptions to Listing Rule 7.1 (as set out in Listing Rule 7.2) and, as it has not yet been approved by Shareholders, it effectively uses up part of the Company’s 15% placement capacity under Listing Rule 7.1. This has the effect of reducing the Company's capacity to issue further Equity Securities without Shareholder approval under Listing Rule 7.1 for the 12-month period following the issue of the Placement Shares. Listing Rule 7.4 allows the shareholders of a listed company to ratify and approve an issue of Equity Securities after it has been made or agreed to be made. If approval is provided, the issue
Page 23
is taken to have been approved under Listing Rule 7.1 and so does not reduce the Company's capacity to issue further Equity Securities without Shareholder approval under that rule. The Company wishes to retain as much flexibility as possible to issue additional equity securities into the future without having to obtain Shareholder approval for such issues under Listing Rule 7.1. Resolution 9 seeks Shareholder approval to ratify the issue of the Placement Shares under and for the purposes of Listing Rule 7.4. If Resolution 9 is passed, the Placement Shares will be excluded in calculating the Company's 15% placement capacity for the purposes of Listing Rule 7.1, effectively increasing the number of Equity Securities it can issue without Shareholder approval over the 12-month period following the date of issue. If Resolution 9 is not passed, the Placement Shares will be included in calculating the Company's 15% placement capacity for the purposes of Listing Rule 7.1, effectively decreasing the number of Equity Securities it can issue without Shareholder approval over the 12-month period following the date of issue. Resolution 9 is an ordinary resolution. 11.3
Specific information required under Listing Rule 7.5 The Company provides the following information as required under Listing Rule 7.5: (a)
The Placement Shares were issued to existing and new sophisticated and institutional investors, who were identified by Bell Potter Securities Limited and Euroz Hartleys Limited (acting as joint lead managers and bookrunners to the Placement) and Ma Moelis Australia (acting as Co-Manager to the Placement) seeking expressions of interest to participate in the Placement from non-related parties of the Company. In accordance with paragraph 7.4 of ASX Guidance Note 21, the Company confirms that no related parties of the Company, members of the Company’s Key Management Personnel, substantial holders of the Company, advisers of the Company or an Associate of any of these parties participated in the Placement.
(b)
21,621,622 Shares, being fully paid ordinary Shares issued on the same terms and conditions as, and ranking equally with, the Company's existing Shares.
(c)
The Placement Shares were issued on 25 May 2026.
(d)
The Placement Shares were issued at an issue price of $9.25 and raised a total of approximately $200 million (before costs).
(e)
The Placement Shares were issued to partially fund the upfront consideration payable for the proposed acquisition of 100% of the shares in MPK.
(f)
The Placement Shares were issued to each participant under placement letters which set out the price of the Placement Shares and the number of Placement Shares to be issued to that participant – the other standard terms are not material.
(g)
The issue of the Placement Shares did not breach Listing Rule 7.1.
(h)
A voting exclusion statement is included in the Notice.
Page 24
11.4
Directors' recommendation The Board recommends that Shareholders vote in favour of Resolution 9.
Page 25
Schedule 1
Definitions
In the Notice, words importing the singular include the plural and vice versa.
0B
1B
2B
3B
4B
5B
6B
7B
$
means Australian dollars.
Annual Report
means the Directors’ Report, the Financial Report, and the Auditor’s Report, in respect of the financial year ended 30 June 2026.
Associate
has the meaning given to that term in the Listing Rules.
ASX
means ASX Limited (ABN 98 008 624 691) and, where the context permits, the Australian Securities Exchange operated by ASX Limited.
Auditor’s Report
means the auditor’s report contained in the Annual Report.
AWST
means Australian Western Standard Time, being the time in Perth, Western Australia.
Board
means the board of Directors.
Chair
means the person appointed to chair the Meeting of the Company convened by the Notice.
Closely Related Party
8B
(a) (b)
37B
38B
means a spouse or child of the member; or has the meaning given in section 9 of the Corporations Act.
Company
means GenusPlus Group Ltd (ACN 620 283 561).
Constitution
means the Constitution of the Company.
Corporations Act
means the Corporations Act 2001 (Cth), as amended.
Director
means a director of the Company.
Directors’ Report
means the annual directors’ report prepared under Chapter 2M of the Corporations Act for the Company and its controlled entities.
Equity Security
has the same meaning as in the Listing Rules.
ESIP
means the GenusPlus Group Ltd Employee Securities Incentive Plan, the subject of Resolution 5.
Explanatory Memorandum
means the explanatory memorandum which forms part of the Notice.
Financial Report
means the financial report contained in the Annual Report.
Group
means the Company and its subsidiaries.
9B
10B
11B
12B
13B
14B
15B
16B
17B
18B
Page 26
Key Management Personnel
has the same meaning as in the accounting standards issued by the Australian Accounting Standards Board and means those persons having authority and responsibility for planning, directing and controlling the activities of the Company, or if the Company is part of a consolidated entity, of the consolidated entity, directly or indirectly, including any Director (whether executive or otherwise) of the Company, or if the Company is part of a consolidated entity, of an entity within the consolidated group.
Listing Rules
means the listing rules of ASX.
Meeting
has the meaning given in the introductory paragraph of the Notice.
MPK
has the meaning given in Section 11.1.
Notice
means this notice of annual general meeting.
Option
means an option to acquire a Share.
Performance Right
means a right to acquire one or more Shares.
Placement
has the meaning given in Section 11.1.
Placement Shares
has the meaning given in Section 11.1.
Proxy Form
means the proxy form attached to the Notice.
Remuneration Report
means the remuneration report of the Company contained in the Annual Report.
Resolution
means a resolution referred to in the Notice.
Schedule
means a schedule to the Notice.
Section
means a section of the Explanatory Memorandum.
Securities
means any Equity Securities of the Company (including Shares, Options and/or Performance Rights).
Share
means a fully paid ordinary share in the capital of the Company.
Shareholder
means the holder of a Share.
Tax Exempt Plan
means the GenusPlus Group Ltd Tax Exempt Share Plan, the subject of Resolution 6.
19B
20B
21B
22B
23B
24B
25B
26B
27B
28B
29B
30B
31B
32B
33B
34B
35B
36B
Page 27
Schedule 2
Summary of material terms of the ESIP
The following is a summary of the material terms and conditions of the ESIP: 1.
(Eligible Participant): A person is eligible to participate in the ESIP (Eligible Participant) if they have been determined by the Board to be eligible to participate in the ESIP from time to time and are an “ESS participant” (as that term is defined in Division 1A of the Corporations Act) in relation to the Company or a subsidiary of the Company. This relevantly includes, amongst others:
(a)
an employee or director of the Company or an individual who provides services to the Company;
(b)
an employee or director of a subsidiary of the Company or an individual who provides services to such subsidiary;
(c)
a prospective person to whom paragraphs (a) or (b) apply;
(d)
a person prescribed by the relevant regulations for such purposes; or
(e)
certain related persons on behalf of the participants described in paragraphs (a) to (d) (inclusive).
(Maximum allocation): The Company must not make an offer of Performance Rights under the ESIP in respect of which monetary consideration is payable (either upfront, or on exercise of convertible securities) where: (a)
the total number of Plan Shares (as defined in paragraph 13 below) that may be issued or acquired upon exercise of the convertible securities offered; plus
(b)
the total number of Plan Shares issued or that may be issued as a result of offers that were both received in this jurisdiction (as defined in section 9 of the Corporations Act) and made under an employee share scheme (as defined in section 1100L(1) of the Corporations Act) at any time during the previous 3 year period,
would exceed 10% of the total number of Shares on issue at the date of the offer or such other limit as may be specified by the relevant regulations or the Company’s Constitution from time to time. The maximum number of equity securities proposed to be issued under the ESIP for the purposes of Listing Rule 7.2, Exception 13 will be as approved by Shareholders from time to time (ASX Limit). This means that, subject to the following paragraph, the Company may issue up to the ASX Limit under the ESIP without seeking Shareholder approval and without reducing its placement capacity under Listing Rule 7.1. The Company will require prior Shareholder approval for the acquisition of Equity Securities under the ESIP by Directors, their Associates and any other person whose relationship with the Company or a Director or a Director’s associate is such that, in ASX’s opinion, the acquisition should be approved by Shareholders. The issue of Securities with Shareholder approval will not count towards the ASX Limit. 3.
(Purpose): The purpose of the ESIP is to: (a)
assist in the reward, retention and motivation of Eligible Participants;
(b)
link the reward of Eligible Participants to Shareholder value creation; and
(c)
align the interests of Eligible Participants with shareholders of the Group (being the Company and each of its subsidiaries), by providing an opportunity to Eligible Participants to receive
Page 28
an equity interest in the Company in the form of Securities. 4.
(ESIP administration): The ESIP will be administered by the Board. The Board may exercise any power or discretion conferred on it by the ESIP rules in its sole and absolute discretion, subject to compliance with applicable laws and the Listing Rules. The Board may delegate its powers and discretion.
(Eligibility, invitation and application): The Board may from time to time determine that an Eligible Participant may participate in the ESIP and make an invitation to that Eligible Participant to apply for Securities on such terms and conditions as the Board decides. An invitation issued under the ESIP will comply with the disclosure obligations pursuant to Division 1 A. On receipt of an invitation, an Eligible Participant may apply for the Securities the subject of the invitation by sending a completed application form to the Company. The Board may accept an application from an Eligible Participant in whole or in part. If an Eligible Participant is permitted in the invitation, the Eligible Participant may, by notice in writing to the Board, nominate a party in whose favour the Eligible Participant wishes to renounce the invitation. A waiting period of at least 14 days will apply to acquisitions of Securities for monetary consideration as required by the provisions of Division 1A.
(Grant of Securities): Performance Rights will be granted under the ESIP. The Company will, to the extent that it has accepted a duly completed application, grant the successful applicant (Participant) the relevant number of Performance Rights, subject to the terms and conditions set out in the invitation, the ESIP rules and any ancillary documentation required.
(Terms of Performance Rights): Each ‘Performance Right’ represents a right to acquire one or more Shares, subject to the terms and conditions of the ESIP. Prior to a Performance Right being exercised, a Participant does not have any interest (legal, equitable or otherwise) in any Share the subject of the Performance Right by virtue of holding the Performance Right. A Participant may not sell, assign, transfer, grant a security interest over or otherwise deal with a Performance Right that has been granted to them. A Participant must not enter into any arrangement for the purpose of hedging their economic exposure to a Performance Right that has been granted to them.
(Vesting of Performance Rights): Any vesting conditions applicable to the grant of Performance Rights will be described in the invitation. An invitation may specify that at the time of exercise of the Performance Rights, the Board will have the discretion to determine whether the Company will, with respect to each vested Performance Right being exercised: (a)
allot and issue, or transfer, one Plan Share to the Participant (Equity Settled); or
(b)
pay a cash amount to the Participant equivalent to the value of a Share as at the date of the notice of exercise (or such other date as specified in the invitation) (Cash Settled).
If the invitation does not specify that the Board will have discretion as described above, the vested Performance Rights being exercised are to be Equity Settled. If all the vesting conditions are satisfied and/or otherwise waived by the Board, a vesting notice will be sent to the Participant by the Company informing them that the relevant Performance Rights have vested. Unless and until the vesting notice is issued by the Company, the Performance Rights will not be considered to have vested. For the avoidance of doubt, if the vesting conditions relevant to a Convertible Security are not satisfied and/or otherwise waived by the Board, that Convertible Security will lapse.
Page 29
(Exercise of Performance Rights): To exercise a Convertible Security, the Participant must deliver a signed notice of exercise to or as directed by the Company, at any time prior to the earlier of any date specified in the vesting notice and the expiry date as set out in the invitation. A Performance Right may not be exercised unless and until that Performance Right has vested in accordance with the ESIP rules, or such earlier date as set out in the ESIP rules.
(Delivery of Shares on exercise of Performance Rights): As soon as practicable after the valid exercise of a Performance Right by a Participant, the Company will issue or cause to be transferred to that Participant the number of Shares to which the Participant is entitled under the ESIP rules and issue a substitute certificate for any remaining unexercised Performance Rights held by that Participant.
(Forfeiture of Performance Rights): Where a Participant who holds Performance Rights ceases to be an Eligible Participant or becomes insolvent, all unvested Performance Rights will automatically be forfeited by the Participant, unless the Board otherwise determines in its discretion to permit some or all of the Performance Rights to vest. Where the Board determines that a Participant has acted fraudulently or dishonestly, or wilfully breached his or her duties to the Group, the Board may in its discretion deem all unvested Performance Rights held by that Participant to have been forfeited. Unless the Board otherwise determines, or as otherwise set out in the ESIP rules: (a)
any Performance Rights which have not yet vested will be forfeited immediately on the date that the Board determines (acting reasonably and in good faith) that any applicable vesting conditions have not been met or cannot be met by the relevant date; and
(b)
any Performance Rights which have not yet vested will be automatically forfeited on the expiry date specified in the invitation.
(Change of control): Subject at all times to the disposal restrictions imposed on the Performance Rights granted under the ESIP, if a change of control event occurs in relation to the Company, or the Board determines that such an event is likely to occur, the Board may in its discretion determine the manner in which any or all of the Participant’s Performance Rights will be dealt with, including, without limitation, in a manner that allows the Participant to participate in and/or benefit from any transaction arising from or in connection with the change of control event.
(Rights attaching to Plan Shares): All Shares issued under the ESIP, or issued or transferred to a Participant upon the valid exercise of a Convertible Security, (Plan Shares) will rank pari passu in all respects with the Shares of the same class. A Participant will be entitled to any dividends declared and distributed by the Company on the Plan Shares and may participate in any dividend reinvestment plan operated by the Company in respect of Plan Shares. A Participant may exercise any voting rights attaching to Plan Shares.
(Disposal restrictions on Securities): If the invitation provides that any Plan Shares or Performance Rights are subject to any restrictions as to the disposal or other dealing by a Participant for a period, the Board may implement any procedure it deems appropriate to ensure the compliance by the Participant with this restriction.
(Adjustment of Performance Rights): If there is a reorganisation of the issued share capital of the Company (including any subdivision, consolidation, reduction, return or cancellation of such issued capital of the Company), the rights of each Participant holding Performance Rights will be changed to the extent necessary to comply with the Listing Rules applicable to a reorganisation of capital at the time of the reorganisation. If Shares are issued by the Company by way of bonus issue (other than an issue in lieu of dividends or by way of dividend reinvestment), the holder of Performance Rights is entitled,
Page 30
upon exercise of the Performance Rights, to receive an allotment of as many additional Shares as would have been issued to the holder if the holder held Shares equal in number to the Shares in respect of which the Performance Rights are exercised. Unless otherwise determined by the Board, a holder of Performance Rights does not have the right to participate in a pro rata issue of Shares made by the Company or sell renounceable rights. 16.
(Participation in new issues): There are no participation rights or entitlements inherent in the Performance Rights and holders are not entitled to participate in any new issue of Shares of the Company during the currency of the Performance Rights without exercising the Performance Rights.
(Amendment of ESIP): Subject to the following paragraph, the Board may at any time amend any provisions of the ESIP rules, including (without limitation) the terms and conditions upon which any Securities have been granted under the ESIP and determine that any amendments to the ESIP rules be given retrospective effect, immediate effect or future effect. No amendment to any provision of the ESIP rules may be made if the amendment materially reduces the rights of any Participant as they existed before the date of the amendment, other than an amendment introduced primarily for the purpose of complying with legislation or to correct manifest error or mistake, amongst other things, or is agreed to in writing by all Participants.
(ESIP duration): The ESIP continues in operation until the Board decides to end it. The Board may from time to time suspend the operation of the ESIP for a fixed period or indefinitely, and may end any suspension. If the ESIP is terminated or suspended for any reason, that termination or suspension must not prejudice the accrued rights of the Participants. If a Participant and the Company (acting by the Board) agree in writing that some or all of the Securities granted to that Participant are to be cancelled on a specified date or on the occurrence of a particular event, then those Securities may be cancelled in the manner agreed between the Company and the Participant.
(Employee Share Trust): The Board may in its sole and absolute discretion use an employee share trust or other mechanism for the purposes of holding securities for holders under the ESIP and delivering Shares on behalf of holders upon exercise of Performance Rights.
Page 31
Schedule 3
Summary of material terms of the Tax Exempt Plan
The following is a summary of the material terms and conditions of the Tax Exempt Plan: 1.
(Overview): The Tax Exempt Plan will be a tax exempt plan (subject to any changes in the law and provided the tax exemptions set out below are met) pursuant to which certain employees may be offered up to $1,000 worth of ordinary shares in the Company on a tax free basis provided certain conditions are satisfied (as set out below).
(Eligible Participant): A person is eligible to participate in the Tax Exempt Plan (Eligible Participant) if they have been determined by the Board to be eligible to participate in the Tax Exempt Plan from time to time and are an employee of the Company or a subsidiary of the Company. The Participants will include at least 75% of permanent Australian-resident employees of the Company or its subsidiaries with at least three years’ service.
(Maximum allocation): The Company must not make an offer of Shares under the Tax Exempt Plan in respect of which monetary consideration is payable where: (a)
the total number of Plan Shares (as defined in paragraph 13 below) that may be issued; plus
(b)
the total number of Plan Shares issued or that may be issued as a result of offers that were both received in this jurisdiction (as defined in section 9 of the Corporations Act) and made under an employee share scheme (as defined in section 1100L(1) of the Corporations Act) at any time during the previous 3 year period,
would exceed 10% of the total number of Shares on issue at the date of the offer or such other limit as may be specified by the relevant regulations or the Company’s Constitution from time to time. The maximum number of Shares proposed to be issued under the Tax Exempt Plan for the purposes of Listing Rule 7.2, Exception 13 will be as approved by Shareholders from time to time (ASX Limit). This means that, subject to the following paragraph, the Company may issue up to the ASX Limit under the Tax Exempt Plan without seeking Shareholder approval and without reducing its placement capacity under Listing Rule 7.1. The Company will require prior Shareholder approval for the acquisition of Shares under the Tax Exempt Plan to Directors, their associates and any other person whose relationship with the Company or a Director or a Director’s associate is such that, in ASX’s opinion, the acquisition should be approved by Shareholders. The issue of Shares with Shareholder approval will not count towards the ASX Limit. 4.
(Purpose): The purpose of the Tax Exempt Plan is to: (a)
assist in the reward, retention and motivation of Eligible Participants;
(b)
link the reward of Eligible Participants to Shareholder value creation; and
(c)
align the interests of Eligible Participants with shareholders of the Group (being the Company and each of its subsidiaries), by providing an opportunity to Eligible Participants to receive an equity interest in the Company in the form of Shares.
(Tax Exempt Plan administration): The Tax Exempt Plan will be administered by the Board. The Board may exercise any power or discretion conferred on it by the Tax Exempt Plan rules in its sole and absolute discretion, subject to compliance with applicable laws and the Listing Rules. The Board may delegate its powers and discretion.
(Eligibility, invitation and application): The Board may from time to time determine that an Eligible Participant may participate in the Tax Exempt Plan and make an invitation to that Eligible Participant to apply for Shares on such terms and conditions as the Board decides providing those conditions meet section 83A-35 of the Income Tax Assessment Act 1997 (Cth). An invitation issued under the
Page 32
Tax Exempt Plan will comply with the disclosure obligations pursuant to Division 1A. On receipt of an invitation, an Eligible Participant may apply for the Shares the subject of the invitation by sending a completed application form to the Company. The Board may accept an application from an Eligible Participant in whole or in part. A waiting period of at least 14 days will apply to acquisitions of Shares for monetary consideration as required by the provisions of Division 1A. 7.
(Grant of Shares): The Company will, to the extent that it has accepted a duly completed application, grant the successful applicant (Participant) the relevant number of Shares, subject to the terms and conditions set out in the invitation, the Tax Exempt Plan rules and any ancillary documentation required. The Board may determine the price at which Shares will be offered to Eligible Participants. Plan Shares will be granted at no cost to the Participant unless the Board determines that some other price is appropriate.
(Rights attaching to Plan Shares): All Shares issued under the Tax Exempt Plan (Plan Shares) will rank pari passu in all respects with the Shares of the same class. A Participant will be entitled to any dividends declared and distributed by the Company on the Plan Shares and may participate in any dividend reinvestment plan operated by the Company in respect of Plan Shares. A Participant may exercise any voting rights attaching to Plan Shares.
(Disposal restrictions on Plan Shares): The Board will have regard to the tax exemption conditions (as set out below) in determining the applicable disposal restrictions. The Board may implement any procedure it deems appropriate to enforce any disposal or other restrictions on the Shares including (without limitation): (a)
imposing a holding lock on the Shares; or
(b)
using an employee share trust to hold the Shares during the relevant restriction period.
The Participants will have full dividend and voting rights during any such restriction period. Where a Participant ceases to be employed by the Company or a Group member prior to the completion of the disposal restriction period, the restrictions will be automatically lifted. 10.
(Adjustments for corporate actions): Subject to the Listing Rules, if the Company reconstructs its capital in any way, Shares acquired under the Tax Exempt Plan will be affected in the same way as other Shares. If a Takeover Bid is made or the Company merges with another company, the Board may, in its discretion and having regard to applicable tax legislation, determine that any disposal restrictions imposed and applying to Plan Shares affected by the change, cease at a time determined by the Board, subject to such a change not breaching the tax exemption requirements of Subdivision 83A-B of the Income Tax Assessment Act 1997 (Cth) (Tax Act).
(Tax exemption conditions): In Australia, there are a number of exemption conditions that must be satisfied for the tax exemption to apply in respect of a Participant. Having regard to the conditions as at the date of this Notice, the Tax Exempt Plan includes the following terms: (a)
The Tax Exempt Plan must not have any conditions that could result in any Participant forfeiting their ownership of Shares.
(b)
The Tax Exempt Plan must be operated so that no Participant will be permitted to dispose of or otherwise deal with their Shares before the earlier of the following times:
Page 33
i. the end of 3 years after the date of allocation or such earlier time the Commissioner of Taxation allows in accordance with section 83A-45(5) of the Tax Act; and ii. the time when the Participant ceases to be employed by any member of the Group within the meaning of section 83A-330 of the Tax Act. In addition, the Participant's 'adjusted taxable income' for the relevant income year must not exceed $180,000. 12.
(Amendment of Tax Exempt Plan): Subject to the following paragraph, the Board may at any time amend any provisions of the Tax Exempt Plan rules, including (without limitation) the terms and conditions upon which any Shares have been granted under the Tax Exempt Plan and determine that any amendments to the Tax Exempt Plan rules be given retrospective effect, immediate effect or future effect provided that the amendment does not affect the ability for the Participant to access the $1,000 tax exemption. No amendment to any provision of the Tax Exempt Plan rules may be made if the amendment materially reduces the rights of any Participant as they existed before the date of the amendment, other than an amendment introduced primarily for the purpose of complying with legislation or to correct manifest error or mistake, amongst other things, or is agreed to in writing by all Participants.
(Tax Exempt Plan duration): The Tax Exempt Plan continues in operation until the Board decides to end it. The Board may from time to time suspend the operation of the Tax Exempt Plan for a fixed period or indefinitely, and may end any suspension. If the Tax Exempt Plan is terminated or suspended for any reason, that termination or suspension must not prejudice the accrued rights of the Participants.
(Employee Share Trust): The Board may in its sole and absolute discretion use an employee share trust or other mechanism for the purposes of holding Shares for holders under the Tax Exempt Plan.
Page 34
Schedule 4
Rule 14 of the Constitution (Approval of Proportional Takeover Bids)
Proportional Takeover Bids
14.1
Definitions In this rule 14:
14.2
(a)
Approving Resolution, in relation to a Proportional Takeover Bid, means a resolution to approve the Proportional Takeover Bid passed in accordance with rule 14.3;
(b)
Proportional Takeover Bid means an off-market bid that is made or purports to be made under section 618(1)(b) of the Corporations Act in respect of a specified proportion of shares included in a class of shares in the Company; and
(c)
Approving Resolution Deadline, in relation to a Proportional Takeover Bid, means the day that is 14 days before the last day of the bid period in respect of the Proportional Takeover Bid.
Transfers not to be registered Despite rules 4.1(g) and 4.2, a transfer giving effect to a takeover contract resulting from the acceptance of an offer made under a Proportional Takeover Bid must not be registered unless and until an Approving Resolution to approve the Proportional Takeover Bid has been passed or is taken to have been passed in accordance with rule 14.3.
14.3
Resolution (a)
(b)
Where offers have been made under a Proportional Takeover Bid, the directors must: (i)
convene a meeting of the persons entitled to vote on the Approving Resolution for the purpose of considering and, if thought fit, passing an Approving Resolution to approve the Proportional Takeover Bid; and
(ii)
ensure that such a resolution is voted on in accordance with this rule 14.3, before the Approving Resolution Deadline in relation to that Proportional Takeover Bid.
The provisions of this constitution that apply to a general meeting of the Company apply: (i)
with any changes that the circumstances require, to a meeting convened under rule 14.3(a); and
(ii)
as if the meeting convened under rule 14.3(a) were a general meeting of the Company.
(c)
The bidder under a Proportional Takeover Bid and any associates of the bidder are not entitled to vote on the Approving Resolution relating to that Proportional Takeover Bid and, if they do vote, their votes must not be counted.
(d)
Subject to rule 14.3(c), a person who, as at the end of the day on which the first offer under the Proportional Takeover Bid was made, held bid class shares is entitled to vote on the Approving Resolution relating to the Proportional Takeover Bid.
Page 35
Legal/97907350_1
14.4
(e)
An Approving Resolution is to be taken to have been passed if the proportion that the number of votes in favour of the resolution bears to the total number of votes on the resolution is greater than 50%, and otherwise is to be taken to have been rejected.
(f)
If an Approving Resolution to approve a Proportional Takeover Bid has not been voted on in accordance with this rule 14.3 as at the end of the day before the Approving Resolution Deadline, an Approving Resolution to approve the Proportional Takeover Bid will be taken to have been passed in accordance with this rule 14.3.
Sunset Rules 14.1, 14.2 and 14.3 cease to have effect at the end of three years beginning: (a)
on the date this constitution is adopted by the Company; or
(b)
where those rules have been renewed in accordance with the Corporations Act, on the date those rules were last renewed.
Page 36
LODGE YOUR VOTE ONLINE https://au.investorcentre.mpms.mufg.com BY MAIL
ABN 86 620 283 561
GenusPlus Group Ltd C/- MUFG Corporate Markets (AU) Limited Locked Bag A14 Sydney South NSW 1235 Australia
FAX BY +61 2 9287 0309 HAND* BY MUFG Corporate Markets (AU) Limited
Parramatta Square, Level 22, Tower 6, 10 Darcy Street, Parramatta NSW 2150 *During business hours Monday to Friday
ENQUIRIES TO ALL Telephone: 1300 554 474
LODGEMENT OF A PROXY FORM
Overseas: +61 1300 554 474
E
This Voting Form (and any Power of Attorney under which it is signed) must be received at an address given above by 10:00am (AWST) on Wednesday, 18 November 2026, being not later than 48 hours before the commencement of the Meeting. Any Voting Form received after that time will not be valid for the scheduled Meeting. Voting Forms may be lodged using the reply paid envelope or:
ONLINE https://au.investorcentre.mpms.mufg.com Login to the Investor Centre website using the holding details as shown on the Voting Form. Select ‘Voting’ and follow the prompts to lodge your vote. To use the online lodgement facility, shareholders will need their “Holder Identifier” - Securityholder Reference Number (SRN) or Holder Identification Number (HIN).
L
BY MOBILE DEVICE Our voting website is designed specifically for voting online. You can now lodge your vote by scanning the QR code adjacent or enter the voting link https://au.investorcentre.mpms.mufg.com into your mobile device. Log in using the Holder Identifier and postcode for your shareholding.
P
QR Code
To scan the code you will need a QR code reader application which can be downloaded for free on your mobile device.
M
HOW TO COMPLETE THIS SHAREHOLDER PROXY FORM YOUR NAME AND ADDRESS
A
This is your name and address as it appears on the Company’s share register. If this information is incorrect, please make the correction on the form. Shareholders sponsored by a broker should advise their broker of any changes. Please note: you cannot change ownership of your shares using this form.
APPOINTMENT OF PROXY
S
If you wish to appoint the Chairman of the Meeting as your proxy, mark the box in Step 1. If you wish to appoint someone other than the Chairman of the Meeting as your proxy, please write the name of that individual or body corporate in Step
- A proxy need not be a shareholder of the Company.
DEFAULT TO CHAIRMAN OF THE MEETING
Any directed proxies that are not voted on a poll at the Meeting will default to the Chairman of the Meeting, who is required to vote those proxies as directed. Any undirected proxies that default to the Chairman of the Meeting will be voted according to the instructions set out in this Proxy Form, including where the Resolutions are connected directly or indirectly with the remuneration of KMP.
VOTES ON ITEMS OF BUSINESS – PROXY APPOINTMENT You may direct your proxy how to vote by placing a mark in one of the boxes opposite each item of business. All your shares will be voted in accordance with such a direction unless you indicate only a portion of voting rights are to be voted on any item by inserting the percentage or number of shares you wish to vote in the appropriate box or boxes. If you do not mark any of the boxes on the items of business, your proxy may vote as they choose. If you mark more than one box on an item your vote on that item will be invalid.
APPOINTMENT OF A SECOND PROXY You are entitled to appoint up to two persons as proxies to attend the Meeting and vote on a poll. If you wish to appoint a second proxy, an additional Proxy Form may be obtained by telephoning the Company’s share registry or you may copy this form and return them both together.
To appoint a second proxy you must: (a) on each of the first Proxy Form and the second Proxy Form state the percentage of your voting rights or number of shares applicable to that form. If the appointments do not specify the percentage or number of votes that each proxy may exercise, each proxy may exercise half your votes. Fractions of votes will be disregarded; and (b) return both forms together.
SIGNING INSTRUCTIONS You must sign this form as follows in the spaces provided: Individual: where the holding is in one name, the holder must sign. Joint Holding: where the holding is in more than one name, either shareholder may sign. Power of Attorney: to sign under Power of Attorney, you must lodge the Power of Attorney with the registry. If you have not previously lodged this document for notation, please attach a certified photocopy of the Power of Attorney to this form when you return it. Companies: where the company has a Sole Director who is also the Sole Company Secretary, this form must be signed by that person. If the company (pursuant to section 204A of the Corporations Act 2001) does not have a Company Secretary, a Sole Director can also sign alone. Otherwise this form must be signed by a Director jointly with either another Director or a Company Secretary. Please indicate the office held by signing in the appropriate place.
CORPORATE REPRESENTATIVES If a representative of the corporation is to attend the Meeting the appropriate “Certificate of Appointment of Corporate Representative” must be received at [email protected] prior to admission in accordance with the Notice of Annual General Meeting. A form of the certificate may be obtained from the Company’s share registry or online at www.mpms.mufg.com/en/mufg-corporate-markets.
IF YOU WOULD LIKE TO ATTEND AND VOTE AT THE ANNUAL GENERAL MEETING, PLEASE BRING THIS FORM WITH YOU. THIS WILL ASSIST IN REGISTERING YOUR ATTENDANCE.
NAME SURNAME ADDRESS LINE 1 ADDRESS LINE 2 ADDRESS LINE 3 ADDRESS LINE 4 ADDRESS LINE 5 ADDRESS LINE 6
X99999999999 X99999999999
PROXY FORM I/We being a member(s) of GenusPlus Group Ltd and entitled to attend and vote hereby appoint:
APPOINT A PROXY OR if you are NOT appointing the Chairman of the Meeting as your proxy, please write the name of the person or body corporate you are appointing as your proxy or failing the person or body corporate named, or if no person or body corporate is named, the Chairman of the Meeting, as my/our proxy to act on my/our behalf (including to vote in accordance with the following directions or, if no directions have been given and to the extent permitted by the law, as the proxy sees fit) at the Annual General Meeting of the Company to be held at 10:00am (AWST) on Friday, 20 November 2026 at Central Park, Level 43, 152 - 158 St Georges Terrace, Perth WA 6000 (the Meeting) and at any postponement or adjournment of the Meeting. Important for Resolutions 1, 4, 5 & 6: If the Chairman of the Meeting is your proxy, either by appointment or by default, and you have not indicated your voting intention below, you expressly authorise the Chairman of the Meeting to exercise the proxy in respect of Resolutions 1, 4, 5 & 6, even though the Resolutions are connected directly or indirectly with the remuneration of a member of the Company’s Key Management Personnel (KMP). The Chairman of the Meeting intends to vote undirected proxies in favour of each item of business.
STEP 1
the Chairman of the Meeting (mark box)
VOTING DIRECTIONS
P
L
E
Proxies will only be valid and accepted by the Company if they are signed and received no later than 48 hours before the Meeting. Please read the voting instructions overleaf before marking any boxes with an T
Resolutions
For Against Abstain*
1 Remuneration Report
9 Ratification of prior issue of Placement Shares
STEP 2
2 Election of Director – Mr Antonio Narvaez 3 Election of Non-Board-Endorsed Director – Mr Stephen Mayne 4 Increase in Non-Executive Directors’ Fees
M
For Against Abstain*
S
5 Approval of Employee Securities Incentive Plan
A
6 Approval of Tax Exempt Plan
7 Renewal of Proportional Takeover Bid Approval Provisions 8 Approval of Financial Assistance
STEP 3
SIGNATURE OF SHAREHOLDERS – THIS MUST BE COMPLETED Shareholder 1 (Individual)
Joint Shareholder 2 (Individual)
Joint Shareholder 3 (Individual)
Sole Director and Sole Company Secretary
Director/Company Secretary (Delete one)
Director
This form should be signed by the shareholder. If a joint holding, either shareholder may sign. If signed by the shareholder’s attorney, the power of attorney must have been previously noted by the registry or a certified copy attached to this form. If executed by a company, the form must be executed in accordance with the company’s constitution and the Corporations Act 2001 (Cth).
GNP PRX2601D
GNP PRX2601D
f you mark the Abstain box for a particular Item, you are directing your proxy not to vote on your behalf on a show of hands or on a poll and your * Ivotes will not be counted in computing the required majority on a poll.
This page is intentionally blank
This page is intentionally blank
312269
Rules 4.7.3 and 4.10.3
Appendix 4G Key to Disclosures Corporate Governance Council Principles and Recommendations Name of entity
GenusPlus Group Ltd ABN/ARBN
Financial year ended:
86 620 283 561
30 June 2026
Our corporate governance statement1 for the period above can be found at:2
☐ ☒
These pages of our annual report: This URL on our website: https://www.genus.com.au/who-we-are/corporate-governance
The Corporate Governance Statement is accurate and up to date as at __ September 2026 and has been approved by the board. The annexure includes a key to where our corporate governance disclosures can be located.3 Date:
21 October 2026
Name of authorised officer authorising lodgement:
Damian Wright, Joint Company Secretary
1 “Corporate governance statement” is defined in Listing Rule 19.12 to mean the statement referred to in Listing Rule 4.10.3 which
discloses the extent to which an entity has followed the recommendations set by the ASX Corporate Governance Council during a particular reporting period. Listing Rule 4.10.3 requires an entity that is included in the official list as an ASX Listing to include in its annual report either a corporate governance statement that meets the requirements of that rule or the URL of the page on its website where such a statement is located. The corporate governance statement must disclose the extent to which the entity has followed the recommendations set by the ASX Corporate Governance Council during the reporting period. If the entity has not followed a recommendation for any part of the reporting period, its corporate governance statement must separately identify that recommendation and the period during which it was not followed and state its reasons for not following the recommendation and what (if any) alternative governance practices it adopted in lieu of the recommendation during that period. Under Listing Rule 4.7.4, if an entity chooses to include its corporate governance statement on its website rather than in its annual report, it must lodge a copy of the corporate governance statement with ASX at the same time as it lodges its annual report with ASX. The corporate governance statement must be current as at the effective date specified in that statement for the purposes of Listing Rule 4.10.3. Under Listing Rule 4.7.3, an entity must also lodge with ASX a completed Appendix 4G at the same time as it lodges its annual report with ASX. The Appendix 4G serves a dual purpose. It acts as a key designed to assist readers to locate the governance disclosures made by a listed entity under Listing Rule 4.10.3 and under the ASX Corporate Governance Council’s recommendations. It also acts as a verification tool for listed entities to confirm that they have met the disclosure requirements of Listing Rule 4.10.3. The Appendix 4G is not a substitute for, and is not to be confused with, the entity's corporate governance statement. They serve different purposes and an entity must produce each of them separately. 2 Tick whichever option is correct and then complete the page number(s) of the annual report, or the URL of the web page, where
your corporate governance statement can be found. You can, if you wish, delete the option which is not applicable. 3 Throughout this form, where you are given two or more options to select, you can, if you wish, delete any option which is not
applicable and just retain the option that is applicable. If you select an option that includes “OR” at the end of the selection and you delete the other options, you can also, if you wish, delete the “OR” at the end of the selection. See notes 4 and 5 below for further instructions on how to complete this form. ASX Listing Rules Appendix 4G (current at 17/7/2020)
Page 1
Appendix 4G Key to Disclosures Corporate Governance Council Principles and Recommendations
ANNEXURE – KEY TO CORPORATE GOVERNANCE DISCLOSURES Corporate Governance Council recommendation
Where a box below is ticked,4 we have followed the recommendation in full for the whole of the period above. We have disclosed this in our Corporate Governance Statement:
Where a box below is ticked, we have NOT followed the recommendation in full for the whole of the period above. Our reasons for not doing so are:5
PRINCIPLE 1 – LAY SOLID FOUNDATIONS FOR MANAGEMENT AND OVERSIGHT 1.1
1.2
1.3
1.4
A listed entity should have and disclose a board charter setting out: (a) the respective roles and responsibilities of its board and management; and (b) those matters expressly reserved to the board and those delegated to management.
☒
☐
set out in our Corporate Governance Statement OR
and we have disclosed a copy of our board charter at:
☐
we are an externally managed entity and this recommendation is therefore not applicable
A listed entity should: (a) undertake appropriate checks before appointing a director or senior executive or putting someone forward for election as a director; and (b) provide security holders with all material information in its possession relevant to a decision on whether or not to elect or re-elect a director.
☒ and we have disclosed the information in our response on page 5 ☐
set out in our Corporate Governance Statement OR
of Genus’ 2026 Corporate Governance Statement
we are an externally managed entity and this recommendation is therefore not applicable
A listed entity should have a written agreement with each director and senior executive setting out the terms of their appointment.
☒ and we have disclosed the information in our response on page 5 ☐
set out in our Corporate Governance Statement OR
of Genus’ 2026 Corporate Governance Statement
we are an externally managed entity and this recommendation is therefore not applicable
The company secretary of a listed entity should be accountable directly to the board, through the chair, on all matters to do with the proper functioning of the board.
☒ and we have disclosed the information in our response on page 5 ☐
set out in our Corporate Governance Statement OR
of Genus’ 2026 Corporate Governance Statement
we are an externally managed entity and this recommendation is therefore not applicable
https://www.genus.com.au/awcontent/genusgroup/document s/genusplus-board-charter.pdf and on page 5 of Genus’ 2026 Corporate Governance Statement
☐
☐
☐
4
Tick the box in this column only if you have followed the relevant recommendation in full for the whole of the period above. Where the recommendation has a disclosure obligation attached, you must insert the location where that disclosure has been made, where indicated by the line with “insert location” underneath. If the disclosure in question has been made in your corporate governance statement, you need only insert “our corporate governance statement”. If the disclosure has been made in your annual report, you should insert the page number(s) of your annual report (eg “pages 10-12 of our annual report”). If the disclosure has been made on your website, you should insert the URL of the web page where the disclosure has been made or can be accessed (eg “www.entityname.com.au/corporate governance/charters/”). 5
If you have followed all of the Council’s recommendations in full for the whole of the period above, you can, if you wish, delete this column from the form and re-format it.
ASX Listing Rules Appendix 4G (current at 17/7/2020)
Page 2
Appendix 4G Key to Disclosures Corporate Governance Council Principles and Recommendations Corporate Governance Council recommendation
Where a box below is ticked,4 we have followed the recommendation in full for the whole of the period above. We have disclosed this in our Corporate Governance Statement:
Where a box below is ticked, we have NOT followed the recommendation in full for the whole of the period above. Our reasons for not doing so are:5
1.5
☒
☐
set out in our Corporate Governance Statement OR
and we have disclosed a copy of our diversity policy at:
☐
we are an externally managed entity and this recommendation is therefore not applicable
☒
☐
set out in our Corporate Governance Statement OR
and we have disclosed the evaluation process referred on page 8 of Genus’ 2026 Corporate Governance Statement. and whether a performance evaluation was undertaken for the reporting period in accordance with that process on page 8 of Genus’ 2026 Corporate Governance Statement.
☐
we are an externally managed entity and this recommendation is therefore not applicable
A listed entity should: (a) have and disclose a diversity policy; (b)
(c)
through its board or a committee of the board set measurable objectives for achieving gender diversity in the composition of its board, senior executives and workforce generally; and disclose in relation to each reporting period: (1) the measurable objectives set for that period to achieve gender diversity; (2) (3)
https://www.genus.com.au/awcontent/genusgroup/documents/d iversity-policy.pdf
and we have disclosed the information referred to on pages 6-7 Genus’ 2026 Corporate Governance Statement.
the entity’s progress towards achieving those objectives; and either: (A)
the respective proportions of men and women on the board, in senior executive positions and across the whole workforce (including how the entity has defined “senior executive” for these purposes); or
(B)
if the entity is a “relevant employer” under the Workplace Gender Equality Act, the entity’s most recent “Gender Equality Indicators”, as defined in and published under that Act. If the entity was in the S&P / ASX 300 Index at the commencement of the reporting period, the measurable objective for achieving gender diversity in the composition of its board should be to have not less than 30% of its directors of each gender within a specified period. 1.6
A listed entity should: (a) have and disclose a process for periodically evaluating the performance of the board, its committees and individual directors; and (b)
disclose for each reporting period whether a performance evaluation has been undertaken in accordance with that process during or in respect of that period.
ASX Listing Rules Appendix 4G (current at 17/7/2020)
Page 3
Appendix 4G Key to Disclosures Corporate Governance Council Principles and Recommendations Corporate Governance Council recommendation
Where a box below is ticked,4 we have followed the recommendation in full for the whole of the period above. We have disclosed this in our Corporate Governance Statement:
Where a box below is ticked, we have NOT followed the recommendation in full for the whole of the period above. Our reasons for not doing so are:5
1.7
☒
☐
set out in our Corporate Governance Statement OR
and we have disclosed the evaluation process referred to on page 8 of Genus’ 2026 Corporate Governance Statement. and whether a performance evaluation was undertaken for the reporting period in accordance with that process at on page 8 Genus’ 2026 Corporate Governance Statement.
☐
we are an externally managed entity and this recommendation is therefore not applicable
A listed entity should: (a) have and disclose a process for evaluating the performance of its senior executives at least once every reporting period; and (b) disclose for each reporting period whether a performance evaluation has been undertaken in accordance with that process during or in respect of that period.
ASX Listing Rules Appendix 4G (current at 17/7/2020)
Page 4
Appendix 4G Key to Disclosures Corporate Governance Council Principles and Recommendations Corporate Governance Council recommendation
Where a box below is ticked,4 we have followed the recommendation in full for the whole of the period above. We have disclosed this in our Corporate Governance Statement:
Where a box below is ticked, we have NOT followed the recommendation in full for the whole of the period above. Our reasons for not doing so are:5
PRINCIPLE 2 - STRUCTURE THE BOARD TO BE EFFECTIVE AND ADD VALUE 2.1
The board of a listed entity should: (a) have a nomination committee which: (1) has at least three members, a majority of whom are independent directors; and (2) is chaired by an independent director,
☒
☐
set out in our Corporate Governance Statement OR
and we have disclosed a copy of the charter of the committee at: https://www.genus.com.au/awcontent/genusgroup/documents/remun eration-nomination-committee-charter.pdf and the information referred to on pages 10-11 Genus’ 2026 Corporate Governance Statement and in the Directors’ Report contained in Genus’ 2026 Annual Financial Report.
☐
we are an externally managed entity and this recommendation is therefore not applicable
A listed entity should have and disclose a board skills matrix setting out the mix of skills that the board currently has or is looking to achieve in its membership.
☒
☐
set out in our Corporate Governance Statement OR
and we have disclosed our board skills matrix on pages 12-13 of Genus’ 2026 Corporate Governance Statement.
☐
we are an externally managed entity and this recommendation is therefore not applicable
A listed entity should disclose:
☒
☐
set out in our Corporate Governance Statement
(a)
and we have disclosed the names of the directors considered by the board to be independent directors on page 11 of Genus’ 2026 Corporate Governance Statement.
and disclose: (3) the charter of the committee; (4) the members of the committee; and (5)
(b)
2.2
2.3
(b)
(c)
as at the end of each reporting period, the number of times the committee met throughout the period and the individual attendances of the members at those meetings; or if it does not have a nomination committee, disclose that fact and the processes it employs to address board succession issues and to ensure that the board has the appropriate balance of skills, knowledge, experience, independence and diversity to enable it to discharge its duties and responsibilities effectively.
the names of the directors considered by the board to be independent directors; if a director has an interest, position, affiliation or relationship of the type described in Box 2.3 but the board is of the opinion that it does not compromise the independence of the director, the nature of the interest, position or relationship in question and an explanation of why the board is of that opinion; and the length of service of each director.
ASX Listing Rules Appendix 4G (current at 17/7/2020)
and, where applicable, the information referred to in paragraph (b) at: Not applicable. and the length of service of each director on page 11 of Genus’ 2026 Corporate Governance Statement.
Page 5
Appendix 4G Key to Disclosures Corporate Governance Council Principles and Recommendations Corporate Governance Council recommendation
Where a box below is ticked,4 we have followed the recommendation in full for the whole of the period above. We have disclosed this in our Corporate Governance Statement:
Where a box below is ticked, we have NOT followed the recommendation in full for the whole of the period above. Our reasons for not doing so are:5
2.4
A majority of the board of a listed entity should be independent directors.
☒ Disclosed on page 11 of Genus’ 2026 Corporate Governance
☐
set out in our Corporate Governance Statement OR
☐
we are an externally managed entity and this recommendation is therefore not applicable
The chair of the board of a listed entity should be an independent director and, in particular, should not be the same person as the CEO of the entity.
☒ Disclosed on page 11 of Genus’ 2026 Corporate Governance
☐
set out in our Corporate Governance Statement OR
☐
we are an externally managed entity and this recommendation is therefore not applicable
A listed entity should have a program for inducting new directors and for periodically reviewing whether there is a need for existing directors to undertake professional development to maintain the skills and knowledge needed to perform their role as directors effectively.
☒ Disclosed on page 11 of Genus’ 2026 Corporate Governance
☐
set out in our Corporate Governance Statement OR
☐
we are an externally managed entity and this recommendation is therefore not applicable
☐
set out in our Corporate Governance Statement
☐
set out in our Corporate Governance Statement
☐
set out in our Corporate Governance Statement
2.5
2.6
Statement.
Statement.
Statement.
PRINCIPLE 3 – INSTIL A CULTURE OF ACTING LAWFULLY, ETHICALLY AND RESPONSIBLY 3.1
A listed entity should articulate and disclose its values.
☒ and we have disclosed our values on pages 4 and 14 of Genus’ 2026 Corporate Governance Statement and on Genus’ website at https://www.genus.com.au/who-we-are/about-us
3.2
A listed entity should:
☒
(a)
and we have disclosed our code of conduct at https://www.genus.com.au/awcontent/genusgroup/documents/corporat of-conduct.pdf and on page 14 of Genus’ 2026 Corporate Governance Statement
(b)
3.3
have and disclose a code of conduct for its directors, senior executives and employees; and ensure that the board or a committee of the board is informed of any material breaches of that code.
A listed entity should: (a) have and disclose a whistleblower policy; and (b)
ensure that the board or a committee of the board is informed of any material incidents reported under that policy.
ASX Listing Rules Appendix 4G (current at 17/7/2020)
☒ and we have disclosed our whistleblower policy at https://www.genus.com.au/awcontent/genusgroup/documents/whistleb policy.pdf and on page 14 of Genus’ 2026 Corporate Governance Statement
Page 6
Appendix 4G Key to Disclosures Corporate Governance Council Principles and Recommendations Corporate Governance Council recommendation
Where a box below is ticked,4 we have followed the recommendation in full for the whole of the period above. We have disclosed this in our Corporate Governance Statement:
Where a box below is ticked, we have NOT followed the recommendation in full for the whole of the period above. Our reasons for not doing so are:5
3.4
☒
☐
A listed entity should: (a) have and disclose an anti-bribery and corruption policy; and (b) ensure that the board or committee of the board is informed of any material breaches of that policy.
ASX Listing Rules Appendix 4G (current at 17/7/2020)
set out in our Corporate Governance Statement
and we have disclosed our anti-bribery and corruption policy at https://www.genus.com.au/awcontent/genusgroup/documents/anti-brib corruption-policy.pdf and on page 14 of Genus’ 2026 Corporate Governance Statement
Page 7
Appendix 4G Key to Disclosures Corporate Governance Council Principles and Recommendations Corporate Governance Council recommendation
Where a box below is ticked,4 we have followed the recommendation in full for the whole of the period above. We have disclosed this in our Corporate Governance Statement:
Where a box below is ticked, we have NOT followed the recommendation in full for the whole of the period above. Our reasons for not doing so are:5
☒
☐
set out in our Corporate Governance Statement
☐
set out in our Corporate Governance Statement
☐
set out in our Corporate Governance Statement
PRINCIPLE 4 – SAFEGUARD THE INTEGRITY OF CORPORATE REPORTS 4.1
The board of a listed entity should: (a) have an audit committee which: (1) has at least three members, all of whom are nonexecutive directors and a majority of whom are independent directors; and (2)
is chaired by an independent director, who is not the chair of the board, and disclose:
and we have disclosed a copy of the charter of the committee at https://www.genus.com.au/awcontent/genusgroup/documents/auditand-risk-management-committee-charter.pdf and the information referred to on pages 10 and 15 of Genus’ 2026 Corporate Governance Statement.
(3) (4)
(b)
4.2
4.3
the charter of the committee; the relevant qualifications and experience of the members of the committee; and (5) in relation to each reporting period, the number of times the committee met throughout the period and the individual attendances of the members at those meetings; or if it does not have an audit committee, disclose that fact and the processes it employs that independently verify and safeguard the integrity of its corporate reporting, including the processes for the appointment and removal of the external auditor and the rotation of the audit engagement partner.
The board of a listed entity should, before it approves the entity’s financial statements for a financial period, receive from its CEO and CFO a declaration that, in their opinion, the financial records of the entity have been properly maintained and that the financial statements comply with the appropriate accounting standards and give a true and fair view of the financial position and performance of the entity and that the opinion has been formed on the basis of a sound system of risk management and internal control which is operating effectively.
☒ Disclosed on page 15 of Genus’ 2026 Corporate Governance
A listed entity should disclose its process to verify the integrity of any periodic corporate report it releases to the market that is not audited or reviewed by an external auditor.
☒ Disclosed on page 16 of Genus’ 2026 Corporate Governance
ASX Listing Rules Appendix 4G (current at 17/7/2020)
Statement.
Statement.
Page 8
Appendix 4G Key to Disclosures Corporate Governance Council Principles and Recommendations Corporate Governance Council recommendation
Where a box below is ticked,4 we have followed the recommendation in full for the whole of the period above. We have disclosed this in our Corporate Governance Statement:
Where a box below is ticked, we have NOT followed the recommendation in full for the whole of the period above. Our reasons for not doing so are:5
A listed entity should have and disclose a written policy for complying with its continuous disclosure obligations under listing rule 3.1.
☒
☐
set out in our Corporate Governance Statement
A listed entity should ensure that its board receives copies of all material market announcements promptly after they have been made.
☒ Disclosed on page 17 of Genus’ 2026 Corporate Governance
☐
set out in our Corporate Governance Statement
A listed entity that gives a new and substantive investor or analyst presentation should release a copy of the presentation materials on the ASX Market Announcements Platform ahead of the presentation.
☒ Disclosed on page 17 of Genus’ 2026 Corporate Governance
☐
set out in our Corporate Governance Statement
☐
set out in our Corporate Governance Statement
☐
set out in our Corporate Governance Statement
☐
set out in our Corporate Governance Statement
PRINCIPLE 5 – MAKE TIMELY AND BALANCED DISCLOSURE 5.1
5.2
5.3
and we have disclosed our continuous disclosure compliance policy at https://www.genus.com.au/awcontent/genusgroup/documents/disclo sure-policy.pdf and on page 17 of Genus’ 2026 Corporate Governance Statement Statement.
Statement.
PRINCIPLE 6 – RESPECT THE RIGHTS OF SECURITY HOLDERS 6.1
A listed entity should provide information about itself and its governance to investors via its website.
☒
A listed entity should have an investor relations program that facilitates effective two-way communication with investors.
☒ Disclosed on page 18 of Genus’ 2026 Corporate Governance
A listed entity should disclose how it facilitates and encourages participation at meetings of security holders.
☒
6.4
A listed entity should ensure that all substantive resolutions at a meeting of security holders are decided by a poll rather than by a show of hands.
☒ Disclosed on page 18 of Genus’ 2026 Corporate Governance Statement.
☐
set out in our Corporate Governance Statement
6.5
A listed entity should give security holders the option to receive communications from, and send communications to, the entity and its security registry electronically.
☒ Disclosed on page 18 of Genus’ 2026 Corporate Governance
☐
set out in our Corporate Governance Statement
6.2 6.3
ASX Listing Rules Appendix 4G (current at 17/7/2020)
and we have disclosed information about us and our governance on our website at https://www.genus.com.au/investor-relations and https://www.genus.com.au/who-we-are/corporate-governance and the information referred to on page 18 of Genus’ 2026 Corporate Governance Statement Statement.
and we have disclosed how we facilitate and encourage participation at meetings of security holders on page 18 of Genus’ 2026 Corporate Governance Statement.
Statement.
Page 9
Appendix 4G Key to Disclosures Corporate Governance Council Principles and Recommendations Corporate Governance Council recommendation
Where a box below is ticked,4 we have followed the recommendation in full for the whole of the period above. We have disclosed this in our Corporate Governance Statement:
Where a box below is ticked, we have NOT followed the recommendation in full for the whole of the period above. Our reasons for not doing so are:5
☒
☐
set out in our Corporate Governance Statement
☐
set out in our Corporate Governance Statement
PRINCIPLE 7 – RECOGNISE AND MANAGE RISK 7.1
The board of a listed entity should: (a) have a committee or committees to oversee risk, each of which: (1)
has at least three members, a majority of whom are independent directors; and
(2) is chaired by an independent director, and disclose: (3) the charter of the committee;
and we have disclosed a copy of the charter of the committee at https://www.genus.com.au/awcontent/genusgroup/documents/auditand-risk-management-committee-charter.pdf and the information referred to on pages 10 and 19 of Genus’ 2026 Corporate Governance Statement and in the Directors’ Report contained in Genus’ 2026 Annual Financial Report.
(4) (5)
(b)
7.2
7.3
the members of the committee; and as at the end of each reporting period, the number of times the committee met throughout the period and the individual attendances of the members at those meetings; or if it does not have a risk committee or committees that satisfy (a) above, disclose that fact and the processes it employs for overseeing the entity’s risk management framework.
The board or a committee of the board should: (a) review the entity’s risk management framework at least annually to satisfy itself that it continues to be sound and that the entity is operating with due regard to the risk appetite set by the board; and (b) disclose, in relation to each reporting period, whether such a review has taken place.
☒
A listed entity should disclose: (a) if it has an internal audit function, how the function is structured and what role it performs; or (b) if it does not have an internal audit function, that fact and the processes it employs for evaluating and continually improving the effectiveness of its governance, risk management and internal control processes.
☐
ASX Listing Rules Appendix 4G (current at 17/7/2020)
and we have disclosed whether a review of the entity’s risk management framework was undertaken during the reporting period on page 19 of Genus’ 2026 Corporate Governance Statement.
☒ set out in our Corporate Governance Statement on page 21 of Genus’ 2026 Corporate Governance Statement.
Page 10
Appendix 4G Key to Disclosures Corporate Governance Council Principles and Recommendations Corporate Governance Council recommendation
Where a box below is ticked,4 we have followed the recommendation in full for the whole of the period above. We have disclosed this in our Corporate Governance Statement:
Where a box below is ticked, we have NOT followed the recommendation in full for the whole of the period above. Our reasons for not doing so are:5
7.4
☒
☐
A listed entity should disclose whether it has any material exposure to environmental or social risks and, if it does, how it manages or intends to manage those risks.
set out in our Corporate Governance Statement
and we have disclosed whether we have any material exposure to environmental and social risks at: page 21 of Genus’ 2026 Corporate Governance Statement and in the Risk Management section in Genus’ 2026 Annual Financial Report. and, if we do, how we manage or intend to manage those risks at: page 21 of Genus’ 2026 Corporate Governance Statement and in the Risk Management section in Genus’ 2026 Annual Financial Report.
ASX Listing Rules Appendix 4G (current at 17/7/2020)
Page 11
Appendix 4G Key to Disclosures Corporate Governance Council Principles and Recommendations Corporate Governance Council recommendation
Where a box below is ticked,4 we have followed the recommendation in full for the whole of the period above. We have disclosed this in our Corporate Governance Statement:
Where a box below is ticked, we have NOT followed the recommendation in full for the whole of the period above. Our reasons for not doing so are:5
☒
☐
set out in our Corporate Governance Statement OR
and we have disclosed a copy of the charter of the committee at:
☐
we are an externally managed entity and this recommendation is therefore not applicable
PRINCIPLE 8 – REMUNERATE FAIRLY AND RESPONSIBLY 8.1
The board of a listed entity should: (a) have a remuneration committee which: (1) has at least three members, a majority of whom are independent directors; and (2) is chaired by an independent director, and disclose: (3) the charter of the committee; (4) the members of the committee; and
https://www.genus.com.au/awcontent/genusgroup/documents/remun eration-nomination-committee-charter.pdf and the information referred to pages 10 and 22 of Genus’ 2026 Corporate Governance Statement and in the Directors’ Report in Genus’ 2026 Annual Financial Report.
(5)
(b)
8.2
8.3
as at the end of each reporting period, the number of times the committee met throughout the period and the individual attendances of the members at those meetings; or if it does not have a remuneration committee, disclose that fact and the processes it employs for setting the level and composition of remuneration for directors and senior executives and ensuring that such remuneration is appropriate and not excessive.
A listed entity should separately disclose its policies and practices regarding the remuneration of non-executive directors and the remuneration of executive directors and other senior executives.
☒
☐
set out in our Corporate Governance Statement OR
and we have disclosed separately our remuneration policies and practices regarding the remuneration of non-executive directors and the remuneration of executive directors and other senior executives at: page 22 of Genus’ 2026 Corporate Governance Statement and in the Remuneration Report contained in Genus’ 2026 Annual Financial Report.
☐
we are an externally managed entity and this recommendation is therefore not applicable
A listed entity which has an equity-based remuneration scheme should: (a) have a policy on whether participants are permitted to enter into transactions (whether through the use of derivatives or otherwise) which limit the economic risk of participating in the scheme; and
☒
☐
set out in our Corporate Governance Statement OR
and we have disclosed our policy on this issue or a summary of it at:
☐
page 22 of Genus’ 2026 Corporate Governance Statement and https://www.genus.com.au/awcontent/genusgroup/documents/securi ties-trading-policy.pdf
we do not have an equity-based remuneration scheme and this recommendation is therefore not applicable OR
☐
we are an externally managed entity and this recommendation is therefore not applicable
(b)
disclose that policy or a summary of it.
ASX Listing Rules Appendix 4G (current at 17/7/2020)
Page 12
Appendix 4G Key to Disclosures Corporate Governance Council Principles and Recommendations Corporate Governance Council recommendation
Where a box below is ticked,4 we have followed the recommendation in full for the whole of the period above. We have disclosed this in our Corporate Governance Statement:
Where a box below is ticked, we have NOT followed the recommendation in full for the whole of the period above. Our reasons for not doing so are:5
ADDITIONAL RECOMMENDATIONS THAT APPLY ONLY IN CERTAIN CASES 9.1
9.2
9.3
A listed entity with a director who does not speak the language in which board or security holder meetings are held or key corporate documents are written should disclose the processes it has in place to ensure the director understands and can contribute to the discussions at those meetings and understands and can discharge their obligations in relation to those documents.
☐
A listed entity established outside Australia should ensure that meetings of security holders are held at a reasonable place and time.
☐
A listed entity established outside Australia, and an externally managed listed entity that has an AGM, should ensure that its external auditor attends its AGM and is available to answer questions from security holders relevant to the audit.
☐
set out in our Corporate Governance Statement OR
☒ we do not have a director in this position and this recommendation is therefore not applicable OR ☐
we are an externally managed entity and this recommendation is therefore not applicable
☐
set out in our Corporate Governance Statement OR
☒ we are established in Australia and this recommendation is therefore not applicable OR
☐
☐
we are an externally managed entity and this recommendation is therefore not applicable
☐
set out in our Corporate Governance Statement OR
☒ we are established in Australia and not an externally managed listed entity and this recommendation is therefore not applicable ☐
we are an externally managed entity that does not hold an AGM and this recommendation is therefore not applicable
☐
set out in our Corporate Governance Statement
ADDITIONAL DISCLOSURES APPLICABLE TO EXTERNALLY MANAGED LISTED ENTITIES
Alternative to Recommendation 1.1 for externally managed listed entities: The responsible entity of an externally managed listed entity should disclose: (a) the arrangements between the responsible entity and the listed entity for managing the affairs of the listed entity; and (b) the role and responsibility of the board of the responsible entity for overseeing those arrangements.
ASX Listing Rules Appendix 4G (current at 17/7/2020)
☐ and we have disclosed the information referred to in paragraphs (a) and (b) at: …………………………………………………………………………….. [insert location]
Page 13
Appendix 4G Key to Disclosures Corporate Governance Council Principles and Recommendations Corporate Governance Council recommendation
Where a box below is ticked,4 we have followed the recommendation in full for the whole of the period above. We have disclosed this in our Corporate Governance Statement:
Where a box below is ticked, we have NOT followed the recommendation in full for the whole of the period above. Our reasons for not doing so are:5
☐
☐
Alternative to Recommendations 8.1, 8.2 and 8.3 for externally managed listed entities: An externally managed listed entity should clearly disclose the terms governing the remuneration of the manager.
ASX Listing Rules Appendix 4G (current at 17/7/2020)
set out in our Corporate Governance Statement
and we have disclosed the terms governing our remuneration as manager of the entity at: …………………………………………………………………………….. [insert location]
Page 14
Appendix 4G Key to Disclosures Corporate Governance Council Principles and Recommendations
ASX Listing Rules Appendix 4G (current at 17/7/2020)
Page 15
CORPORATE GOVERNANCE STATEMENT 2026
ABOUT THIS STATEMENT Establishing our commitment
OUR VALUES
What is Modern Slavery?
GenusPlus Group Ltd (Genus or Company) is committed to maintaining high standards of corporate governance and conducting its business with integrity, accountability and transparency. The Company has adopted governance practices that are aligned with the ASX Corporate Governance Council’s in the fourth edition of its Corporate Governance Principles and Recommendations (ASX Recommendations) ,recognising that effective governance is fundamental to sustainable longterm performance and the creation of value for security holders and other stakeholders. This Corporate Governance statement outlines the Company’s governance framework and the manner in which Genus has applied the ASX Recommendations during the reporting period. For the reporting period ending 30 June 2026, the Company’s Board of Directors (Board) is confident that the Company’s governance practices have consistently adhered to the ASX Recommendations. This Statement outlines Genus’ key governance principles and practices, which are regularly reviewed and updated to ensure they are current and in compliance with legal requirements and in accordance with the evolving corporate governance landscape. This Statement and more comprehensive details on Genus’ governance policies, including Board and Committee Charters, are available in the "Corporate Governance" section of the Company’s website: www.genus.com.au/who-weare/corporate-governance. This Statement is current as at 1 October 2026 and has been approved by the Board. This Statement should be read in conjunction with the Company’s 2026 Annual Report.
David Riches Managing Director 2
CONTENTS
01 ABOUT US......................................................4 02 MANAGEMENT............................................5 03 BOARD STRUCTURE...................................9 04 CULTURE.......................................................14 05 REPORTING..................................................15 06 DISCLOSURES.............................................17 07 SECURITY.....................................................18 08 RISK MANAGEMENT................................19 09 REMUNERATION.......................................22 10 ADDITIONAL................................................23
3
01 ABOUT US Our Vision, Mission & Values
Through developing strong, effective client relationships we create smart and integrated solutions that bring visions to life. We build client relationships for the long term – through the construction and maintenance of critical power and communications infrastructure for tomorrow and beyond. We are proud of our excellent track record in delivering successful projects. Safety is and will always be paramount and underpins our approach in everything we do. Leveraging a robust strategic platform, we focus on clients who seek purposedriven and innovative power and communication solutions that offer exceptional value without compromising on quality.
OUR VISION The Company’s vision is to become Australia’s leading services provider in the design, construction and maintenance of electricity transmission, electricity distribution and communications infrastructure.
OUR MISSION To be the contractor of choice within the industries in which we operate, creating sector leading returns, continuous improvement and innovation, real life value for our people and the community, whilst exceeding industry expectations.
4
02 MANAGEMENT Laying the foundations
Principle 1: Lay Solid foundations for management and oversight A listed entity should establish and disclose the respective roles and responsibilities of its board and management and how their performance is monitored and evaluated. Genus’ Board is committed to maintaining a robust governance framework that clearly defines the roles, responsibilities and accountability of the Board and management, while ensuring their performance is appropriately monitored and evaluated.
The Board operates under a Board Charter, which is publicly available on the Company’s website. The Charter outlines the respective roles and responsibilities of the Board, the Chair, the Managing Director, management and the Company Secretary, and distinguishes between matters reserved for the Board and those delegated to management or Board committees. The Company Secretary reports directly to the Board through the Chair and plays a key role in supporting the effective operation of the Board and its committees.
The appointment of Directors and senior executives is governed by a formal process overseen by the Remuneration and Nomination Committee (RNC). Appropriate background and probity checks are undertaken prior to appointment, and all Directors and senior executives enter into written agreements setting out the terms of their appointment. When security holders are asked to elect or re-elect a Director, the Company provides all material information relevant to the decision, including the candidate’s biographical details, skills, experience, independence, and any other interests that may reasonably be considered to influence their judgement.
5
Genus recognises that a diverse and inclusive workforce is fundamental to its long-term success. The Company is committed to fostering a workplace culture where individuals from a broad range of backgrounds, experiences and perspectives are valued, respected and empowered to contribute.
To support this commitment, Genus maintains an Equal Employment Opportunity Policy, Diversity Policy and Corporate Code of Conduct, which are available to employees via the Company’s intranet, GenConnect, and publicly on the Company’s website. The Company also promotes inclusion and employee wellbeing through participation in annual initiatives such as R U OK? Day and Women’s Health Month. In accordance with its Diversity Policy, the Board is responsible for setting, monitoring and reporting against measurable diversity objectives, including objectives relating to gender diversity. The Board has established the following measurable objectives to support improved gender representation across the Group:
The Board remains committed to achieving these objectives and continues to support initiatives that promote diversity through recruitment, retention, career development and leadership opportunities. Genus actively seeks to create an inclusive workplace that encourages greater participation and advancement of women across all levels of the organisation. The Company’s approach to diversity extends beyond professional skills and experience and encompasses a broad range of characteristics, including gender, age, disability, cultural and socio-economic background, family and caring responsibilities, religious beliefs, sexual orientation, gender identity, perspectives and lived experiences. Genus acknowledges that the infrastructure construction sector has historically been male-dominated, particularly in operational and field-based roles. While this can affect the availability of experienced female candidates in certain disciplines, the Company remains focused on improving gender diversity across its workforce. Women continue to have strong representation in the Company’s corporate, professional and administrative functions, including its head office and regional offices throughout Australia. Across the Group, Genus is committed to maintaining female workforce participation at or above the relevant industry average and to continuing to improve representation through targeted diversity and inclusion initiatives.
6
Diversity The Company recognises that a diverse and inclusive workforce contributes to stronger organisational performance, innovation and decision-making. The Board is responsible for setting measurable diversity objectives and monitoring progress against those objectives. The Board's FY27 measurable diversity objectives are set out below:
FY26 Outcome Female Board Representation Female Senior Executives
FY27 Goal
Appoint and maintain at least one female Non-Executive Director by 30 0% (0 of 5 directors) June 2027 (20% of the Board) 28.57%
Female Management
16.03%
Female Workforce Participation
15.11%
Diversity, inclusion & pay equity initiatives
Achieved
Maintain female representation of at least 28% and target 30% or greater Increase female representation to 18% Increase female participation to at least 16% and maintain participation above relevant industry benchmarks Continue annual pay equity reviews and diversity and inclusion initiatives, including consideration of diversity in recruitment, succession planning and talent development
As at 30 June 2026, women represented 28.57% of senior executives, 16.03% of management positions and 15.11% of the Group's workforce. While the Company achieved its FY26 objectives for senior executive, management and workforce representation, the Board acknowledges that no female directors served on the Board during the reporting period. Accordingly, the appointment of at least one female Non-Executive Director has been adopted as a priority diversity objective for FY27. The Board will continue to monitor progress against these objectives and report annually on outcomes achieved.
7
GOVERNANCE FRAMEWORK
Performance evaluation is a key component of Genus’ governance framework and supports the effective oversight and accountability of the Board and management.
The performance of the Board, its committees and individual Directors is reviewed periodically against their respective charters, responsibilities and objectives, with the process overseen by the RNC. The Board also undertakes an annual review of the Managing Director’s performance, while the Managing Director conducts annual performance assessments of senior executives. During FY26, formal performance evaluations were completed for the Board, its committees, individual Directors and senior executives. Through these processes, Genus seeks to ensure that roles and responsibilities remain clearly defined and aligned with the Company’s strategic objectives, appointments are transparent and accountable, and performance is regularly assessed to support continuous improvement and long-term value creation.
8
03 BOARD STRUCTURE Size, composition, skills & commitment
Principle 2: Structure the Board to add value. A listed entity should have a board of an appropriate size, composition, skills and commitment to enable it to discharge its duties effectively.
THE BOARD OF DIRECTORS
MANAGING DIRECTOR David Riches
NON-EXECUTIVE CHAIRMAN Simon High
NON-EXECUTIVE DIRECTOR Tony Narvaez
NON-EXECUTIVE DIRECTOR Jose Martins
9
BOARD COMMITTEES As and when required, the Board establishes special purpose sub-committees to give detailed consideration to specific matters or projects. Board Committees report to and make recommendations to the Board. The Chair of each Committee reports at the Board meeting following the relevant Committee meeting.
Committee as at October 2026
Audit and Risk Committee (ARC) -Paul Gavazzi (Chairman) -José Martins -Tony Narvaez
Remuneration and Nomination Committee (RNC) -José Martins (Chairman) -Paul Gavazzi -David Riches
Composition Requirements
Responsibilities
The Committee should have at least three members, all being non-executive Directors, with a majority being independent. Members must be able to read and understand financial statements. The ARC Chair must be independent, not the Board Chair, and have leadership experience and a strong finance, accounting, or business background. The Board appoints, removes, and replaces Committee members by resolution. External auditors, Directors, and senior executives may be invited to meetings at the ARC’s discretion. The Board acknowledges that these composition requirements may not always be possible.
Financial Reporting: Review and ensure the integrity of financial statements, oversee external audits, assess adequacy of external reporting, and review the impact of accounting policy changes. External Auditors: Recommend procedures for auditor selection and rotation, review performance, approve audit plans and fees, and ensure auditor independence and availability to answer shareholder questions. Internal Audit: Monitor internal audit needs, assess internal audit performance, and review internal controls and risk management. Corporate Reports: Ensure the integrity of unaudited periodic corporate reports and disclose verification processes. Risk Management: Oversee risk management systems, review the risk management framework annually, and monitor safety, health, environmental, and quality risk management processes. Other: Oversee Whistleblower protection, the company’s insurance program, and related party transactions
The RNC will have at least three members, with a majority being independent Non-Executive Directors. It will be chaired by an independent Non-Executive Director appointed by the Board. The Board can add, remove, or replace Committee members by resolution.
Board Composition & Performance: Ensure appropriate size, diversity, and skills on the Board; recommend appointments, re-elections, and removals; assess Board performance and succession plans; oversee Director induction and professional development. Recruitment: Conduct background checks and set appointment terms for Directors and Senior Management. Selection Process: Develop criteria for selecting Board candidates, including skills, experience, and diversity, and disclose relevant candidate information. Executive Remuneration: Review and approve executive remuneration policies, incentive plans, and termination payments for the Managing Director and Senior Management. Non-Executive Director Remuneration: Set remuneration structures for Non-Executive Directors, ensuring they stay within shareholderapproved limits and do not include equity-based incentives or performance-based pay. Other Responsibilities: Oversee executive incentive plans, approve awards, and manage the policy on risk-limiting transactions related to these plans. Perform additional duties as deemed appropriate by the Board.
10
At the end of each reporting period the Company discloses in its annual report the number of times the various committees have met throughout the period and the individual attendances of the members at those meetings. Role
Name
Independent
Length of Service
David Riches
Managing Director
No
6 July 2017 - present ~9 years 3 months
Simon High
Director
Yes
23 October 2017 – present ~8 years 11 months
Paul Gavazzi
Director
Yes
27 November 2017 – present ~8 years 10 months
Jose Martins
Director
Yes
3 January 2018 – present ~8 years 9 months
Tony Narvaez
Director
Yes
20 November 2025 - present ~0 years 11 months
Genus recognises that an effective Board requires an appropriate balance of skills, experience, independence and diversity to oversee the Company's strategy and deliver sustainable value for security holders. Board composition, succession planning and Board renewal are overseen by the RNC, which operates under a charter available on the Company's website. The Board maintains a skills matrix to identify the competencies and attributes required to support the Company's strategic objectives. The RNC reviews the matrix regularly to assess whether the Board possesses the appropriate mix of capabilities across areas including infrastructure, financial management, governance, risk oversight, health and safety, stakeholder engagement and sustainability. Details of each Director's skills and experience are set out in the Annual Report. Collectively, the Directors bring extensive industry knowledge and expertise that the Board considers appropriate for the Company's business and strategic direction. Director independence is assessed regularly in accordance with the Board Charter and the ASX Corporate Governance Principles and Recommendations. Directors are required to disclose any interests, positions, associations or relationships that may affect, or appear to affect, their independent judgement. As at the date of this Statement, a majority of the Board comprises independent non-executive Directors, and the Board has determined that no disclosed interests materially interfere with the exercise of independent judgement. The Chair, Mr Simon High, is an independent non-executive Director and is not the Managing Director or Chief Executive Officer. The tenure of each Director is disclosed in the Annual Report and on the Company's website. The Board recognises that tenure is one of several factors considered when assessing independence and that ongoing Board renewal and succession planning are important to maintaining an effective and high-performing Board. Genus has a structured induction program for newly appointed Directors, including briefings with the Managing Director and senior management, reviews of key governance and operational documents, and visits to major operational sites. The program is designed to provide Directors with a comprehensive understanding of the Company's operations, strategy, governance framework and risk profile. Ongoing professional development is supported through regular industry, regulatory and governance updates, as well as access to external education and training programs where appropriate. Through these practices, the Board seeks to ensure it remains appropriately structured, independent and equipped with the skills, experience and expertise necessary to effectively oversee the Company and support the creation of long-term value for stakeholders. Details of the number of meetings held by the RNC during FY26 and the attendance of individual committee members are disclosed in the Company's 2026 Annual Report
11
Expert – substantial career experience in senior executive, director or professional roles Substantial – considerable experience at director management or professional levels Familiar – some knowledge and can participate in discussion.
SKILLS MATRIX
12
SKILLS MATRIX (CONT’D)
13
04 CULTURE Lawful, Ethical & Responsible Conduct
Principle 3: Instill a culture of acting lawfully, ethically and responsibly Genus is committed to fostering a culture that promotes integrity, accountability, inclusion and responsible decision-making at every level of the organisation. The Company's values, vision and mission provide the foundation for how we work, interact and make decisions, shaping a culture where people are empowered to do the right thing, speak up when concerns arise, and act in the best interests of the Company and its stakeholders. To support this culture, Genus has adopted a Code of Conduct that applies to Directors, officers, employees, contractors and suppliers. The Code sets clear expectations for ethical and professional behaviour and reinforces the standards of honesty, respect, accountability and integrity that underpin the Company's values. Any material breaches of the Code are reported to the Board, ensuring appropriate oversight and accountability. Genus recognises that a strong culture is supported not only by values, but by clear governance frameworks and trusted reporting channels. The Company maintains a Whistleblower Policy, which is available on its website and provides a framework for employees and other stakeholders to confidentially, and where desired anonymously, raise concerns regarding misconduct or other disclosable matters. The policy outlines the protections available to whistleblowers and the process for investigating disclosures. The Board is informed of any material matters reported under the policy. The Company also maintains an Anti-Bribery and Corruption Policy that applies to Directors, officers, employees, contractors, suppliers and business partners. The policy prohibits bribery, corruption and other improper conduct and reinforces Genus' commitment to conducting business fairly, ethically and in compliance with applicable laws. Any material breaches of the policy, or incidents involving bribery or corruption, are reported to the Board. BRIDGEWATER, TAS During FY26, Genus further strengthened its governance framework through the introduction of Human Rights and Artificial Intelligence policies, reflecting the MAJOR PROJECTS Company's commitment to responsible business practices, emerging risks, and evolving stakeholder expectations. Together, these values, policies and governance practices help to foster a culture of trust, accountability and ethical conduct. They support Genus' commitment to acting lawfully, responsibly and with integrity, while creating a workplace in which employees are empowered to contribute to the Company's long-term success.
At Genus, culture is not viewed as a standalone initiative, but as the practical expression of the Company's values in the decisions made every day by its people. 14
05 REPORTING Safeguarding Integrity.
Principle 4: Safeguard integrity in corporate reporting A listed entity should have appropriate processes to verify the integrity of its corporate reports. Genus is committed to maintaining the integrity, transparency and accuracy of its corporate reporting. Effective governance, rigorous oversight and strong internal controls underpin the Company's approach to both financial and non-financial reporting, ensuring that stakeholders receive reliable, balanced and timely information. Oversight of the Company's reporting and assurance framework is supported by the Audit & Risk Committee (ARC), which operates under a formal charter available on the Company's website. The ARC assists the Board in fulfilling its responsibilities by overseeing the integrity of financial reporting, the effectiveness of risk management and internal control systems, and compliance with applicable legal and regulatory requirements. The Board appoints ARC members having regard to their financial literacy, professional qualifications and relevant industry experience. Details of the qualifications, skills and experience of each ARC member are provided in the Annual Report and on the Company's website. The ARC meets regularly throughout the year, and details of committee meetings and member attendance are disclosed in the Company's FY2026 Annual Report. Prior to approving the Company's financial statements, the Board receives written declarations from the Managing Director and Chief Financial Officer confirming that, in their opinion, the Company's financial records have been properly maintained, the financial statements comply with applicable accounting standards and statutory requirements, and the statements present a true and fair view of the Company's financial position and performance. Through these processes, the Board seeks to ensure that the Company's reporting is subject to appropriate oversight and review, supporting investor confidence and informed decision-making by security holders and other stakeholders.
15
The ARC oversees these processes and regularly engages with management and the external auditor to help ensure the integrity and effectiveness of the Company's reporting framework. Genus recognises the importance of maintaining the integrity of all corporate reporting, including market disclosures and other reports that are not subject to external audit or review. The Company has adopted a Disclosure Policy, administered by a dedicated Disclosure Committee, which establishes clear processes for reviewing and verifying the accuracy, completeness and balance of information before it is released to the market. As part of this process, information is validated against source documents and reviewed in consultation with relevant business units and subject matter experts. Draft disclosures and reports are subject to review by senior management, including the Managing Director and Chief Financial Officer, before being considered and approved by the Board where appropriate. Through these governance and verification processes, Genus seeks to ensure that its financial and non-financial reporting is accurate, balanced, timely and reliable, providing security holders and other stakeholders with confidence in the Company's performance, strategy and prospects.
16
06 DISCLOSURE Timely and balanced.
Principle 5: Make timely and balanced disclosure. A listed entity should make timely and balanced disclosure of all matters concerning it that a reasonable person would expect to have a material effect on the price or value of its securities.
Genus is committed to providing timely, balanced and transparent disclosure of information that a reasonable person would expect to have a material effect on the price or value of the Company's securities. Effective disclosure practices are fundamental to maintaining market integrity and ensuring that investors have equal and timely access to material information.
The Company has adopted a Disclosure Policy, available on its website, which establishes the framework and processes for complying with its continuous disclosure obligations under the ASX Listing Rules and applicable legislation. The policy is supported by a dedicated Disclosure Committee, which assists in identifying, assessing and escalating potentially market-sensitive information to ensure disclosure obligations are met in a timely and consistent manner. In accordance with the Disclosure Policy, all material announcements released to the ASX are promptly provided to the Board. This ensures Directors remain informed of material matters disclosed to the market and can effectively discharge their governance responsibilities. Consistent with the Company's commitment to equal access to information, all new and substantive investor or analyst presentations are released to the ASX Market Announcements Platform before the presentation is delivered. This approach helps ensure that material information is made available to all investors at the same time and supports fair and informed trading in the Company's securities. Through these practices, Genus seeks to maintain a culture of transparency and accountability while ensuring compliance with its continuous disclosure obligations and promoting investor confidence in the Company's communications.
17
07 SECURITY HOLDERS Respect the rights of security holders.
Principle 6: Respect the rights of securityholders A listed entity should provide its security holders with appropriate information and facilities to allow them to exercise their rights as security holders effectively. Genus is committed to facilitating effective engagement with its security holders and ensuring they have access to timely, relevant and accessible information to enable them to exercise their rights as investors. The Company seeks to promote open, transparent and meaningful communication with security holders through a range of channels and engagement opportunities.
Information about the Company, its operations and its governance framework is available on the Company's website, including ASX announcements, annual and sustainability reports, corporate governance documents, Board and executive profiles, shareholder information and key corporate information. To support effective two-way communication, Genus has adopted a Shareholder Communication Policy and maintains an active investor relations program. The Company provides security holders with multiple channels through which to access information, communicate with the Company and engage with management and the Board. Relevant announcements, reports and presentations are made available on the Company's website, and security holders can elect to receive communications electronically through the Company's share registry. Genus is committed to ensuring that all investors have equal access to material information. Investor and analyst briefings are conducted in accordance with the Company's Disclosure Policy, and all new and substantive investor presentations are released to the ASX prior to being presented. Where appropriate, investor briefings and presentations are made accessible through webcasts or teleconferences to encourage broader participation. The Annual General Meeting (AGM) remains an important forum for communication between the Company, its Board and security holders. Shareholders are encouraged to attend, participate and ask questions of the Board, management and the Company's external auditor. Notices of meeting, explanatory materials and voting information are made available through the Company's website and share registry platform to facilitate informed participation. To support accessibility and participation, shareholders are able to lodge votes electronically and appoint proxies where they are unable to attend a meeting in person. Following each meeting, voting outcomes are released to the ASX and published on the Company's website. In accordance with the ASX Corporate Governance Principles and Recommendations, all substantive resolutions are decided by poll, ensuring that the voting outcome accurately reflects the views of security holders. Genus encourages security holders to receive communications electronically through the Company's share registry, supporting more timely, efficient and environmentally sustainable engagement. Through these practices, Genus seeks to foster a culture of transparency, accessibility and constructive engagement, ensuring security holders are well informed and able to participate effectively in the governance of the Company. 18
08 RISK MANAGEMENT Recognise and manage risk.
Principle 7: Recognise and manage risk A listed entity should establish a sound risk management framework and periodically review the effectiveness of that framework. Genus is committed to maintaining a strong and proactive risk management culture that supports the achievement of its strategic objectives, protects stakeholder value and promotes informed decision-making across the business. The Board recognises that effective risk management is critical to the long-term sustainability and resilience of the Company and has delegated oversight of the risk management framework to the Audit & Risk Committee (ARC).
The Company's risk management framework is aligned with AS/NZS ISO 31000:2018 and is supported by a suite of governance documents, including the Risk Management Policy, Risk Appetite Statement, Risk Management Standard and Risk Management Procedure. Together, these documents provide a structured and consistent approach to identifying, assessing, monitoring and managing risks and opportunities across the Group, while embedding risk management into strategic planning, operational decision-making and business performance processes. The ARC reviews the effectiveness of the risk management framework at least annually and receives regular reports from management on emerging risks, control effectiveness and risk mitigation activities. Management is responsible for implementing and maintaining the framework, monitoring risk exposures, and ensuring that appropriate controls and treatment plans are in place and operating effectively. To support alignment between the Company's strategic objectives and risk profile, the Board receives regular reporting on principal risks, emerging risk trends, compliance matters, internal audit findings and the progress of key risk treatment initiatives. The Board also reviews and approves the Company's annual business plans and budgets and monitors performance against those plans throughout the year. Through these practices, Genus continues to enhance its risk management capability and strengthen organisational resilience, ensuring that risk considerations remain embedded in decision-making and that the Company is well positioned to respond to evolving business, regulatory and market conditions.
19
RISK MANAGEMENT FRAMEWORK
20
Genus maintains a risk management and internal control framework designed to support the delivery of its strategic objectives, safeguard its people and assets, and promote the effective management of risk across the Group.
While the Company does not maintain a dedicated internal audit function, it has established a range of governance, assurance and review processes that provide ongoing oversight of risk management, compliance and internal controls. These processes include regular reviews of governance policies and frameworks, monthly operational and project performance reviews, targeted assurance activities, and oversight by the Board and its committees. During FY26, Genus continued to strengthen its assurance framework through enhanced enterprise risk management processes and refinement of the Group risk register. These initiatives have further embedded risk management and accountability across the business and enhanced visibility of emerging and strategic risks. Safety, Health, Environment and Quality (SHEQ) performance remains a key focus area. Comprehensive SHEQ audits, inspections and compliance reviews are undertaken across the Group, with findings, trends and improvement actions reported regularly to management, the Audit & Risk Committee and the Board. Lessons learned from operational activities, investigations and assurance reviews are incorporated into continuous improvement initiatives to strengthen controls and drive better business outcomes. Genus is exposed to a range of economic, environmental and social sustainability risks that may affect its financial performance, operations and long-term growth prospects. These include market and economic conditions, health and safety risks, environmental impacts, workforce capability and retention, project delivery challenges, supply chain risks and changing regulatory requirements. The Company manages these risks through a combination of disciplined project selection and tender review processes, robust commercial and financial controls, structured project risk management methodologies, enterprise risk oversight, and SHEQ management systems aligned with recognised Australian standards. Ongoing investment in employee development, leadership capability, succession planning and sustainability initiatives further supports the Company's ability to identify, manage and respond to evolving risks and opportunities. Through these processes, Genus seeks to strengthen organisational resilience, support informed decision-making and maintain an effective system of risk management and internal control that is appropriate for the scale and complexity of the Group's operations. Further information regarding the Company's material business risks and the measures in place to manage those risks is provided in the FY2026 Annual Report.
21
09 REMUNERATION Attract, retain and motivate.
Principle 8: Remunerate fairly and responsibly A listed entity should pay director remuneration sufficient to attract and retain high quality directors and design its executive remuneration to attract, retrain and motivate high quality senior executives and to align their interests with the creation of value for security holders and with the entity’s values and risk appetite. Genus is committed to maintaining a remuneration framework that attracts, retains and motivates high-calibre Directors and executives, while aligning remuneration outcomes with the Company's strategic objectives, values, risk appetite and the creation of sustainable long-term value for security holders. Oversight of remuneration matters is supported by the Remuneration and Nomination Committee (RNC), which assists the Board in reviewing remuneration practices, succession planning and talent management across the Group. Details of RNC meetings and member attendance are disclosed annually in the Company's Annual Report. Genus maintains separate remuneration structures for non-executive Directors, executive Directors and senior executives, reflecting their respective responsibilities and accountabilities. The Board, having regard to recommendations from the RNC, reviews and approves remuneration arrangements to ensure they remain competitive, equitable and aligned with market practice and shareholder interests. Independent external remuneration advice may be obtained where appropriate. Executive remuneration comprises a mix of fixed remuneration, short-term incentives linked to the achievement of financial, operational and strategic objectives, and long-term incentive arrangements designed to align executive performance with sustainable shareholder value creation. The remuneration framework is intended to reward both the achievement of annual performance objectives and the delivery of long-term business outcomes. The remuneration of executive Directors is determined by the Board, with affected Directors excluded from deliberations relating to their own remuneration. Non-executive Directors receive fixed fees, including additional fees for Board committee responsibilities where applicable, but do not participate in performance-based incentive arrangements or equity incentive schemes. The aggregate maximum remuneration payable to nonexecutive Directors is $600,000 per annum, as approved by shareholders and set out in the Company's Constitution. Non-executive Directors may also be reimbursed for reasonable expenses incurred in performing their duties and, where appropriate, may receive additional remuneration for services outside the ordinary scope of their Board responsibilities. Senior executive remuneration is structured to support performance, accountability and retention. Remuneration arrangements typically include fixed remuneration, performance-based incentives, superannuation and participation in equity-based incentive programs, promoting alignment between executive decision-making and the long-term interests of security holders. To reinforce alignment with shareholder interests and prudent risk management, Genus prohibits Directors, officers and employees from entering into transactions that limit the economic risk of participating in unvested equity-based remuneration arrangements or securities subject to holding locks. These restrictions are contained in the Company's Securities Trading Policy, which is available on the Company's website. Through this framework, Genus seeks to ensure remuneration outcomes are fair, transparent and aligned with performance, accountability and long-term value creation. The framework supports the attraction, retention and development of talented leaders, while promoting behaviours consistent with the Company's values and strategic objectives.
22
10 ADDITIONAL
Principle 9: Additional recommendations that apply only in certain cases The following additional recommendations apply to the entities described within them. Recommendation 9.1: A listed entity with a director who does not speak the language in which board or security holder meetings are hold or key corporate documents are written should disclose the processes it has in place to ensure the director understands and can contribute to the discussions at those meetings and understands and can discharge their obligations in relation to those documents. Not applicable to Genus. Recommendation 9.2: A listed entity established outside Australia should ensure that meetings of security holders are held at a reasonable place and time. Not applicable to Genus. Recommendation 9.3: A listed entity established outside Australia, and an externally managed listed entity that has an AGM, should ensure that its external auditor attends its AGM and is available to answer questions from security holders relevant to the audit. Not applicable to Genus.
23
genus.com.au
HIGHLIGHTS: •
GenusPlus has secured significant power infrastructure contracts with Western Power and Fortescue
•
The awards include major transmission, distribution, maintenance and customer connection works in Western Australia
•
The aggregate value of the contracts is approximately $255 million
•
The Western Power contracts are scheduled for delivery progressively through to early 2029
•
The Fortescue contracts have planned completion fourth-quarter 2027
Infrastructure construction, maintenance and service provider GenusPlus Group Ltd (ASX: GNP) (Genus or the Company) is pleased to announce that it has secured a number of significant contract awards with Western Power and Fortescue, with an aggregate value of approximately $255 million. The awards further strengthen Genus’ contracted project pipeline across the utilities and resources sectors. Western Power Contract Awards Genus has been awarded contracts by Western Power for the Clean Energy Link – East project (CEL-E Project), transmission and distribution maintenance program packages and a customer connection package associated with Waddi Wind Farm. The CEL-E Project involves the design and construction of a major augmentation to an existing 330kV terminal to increase transmission network capacity and support the connection and transport of renewable energy from Western Australia’s southern region. The project is expected to be completed in early 2029. The transmission and distribution maintenance program packages comprise works across the South West Interconnected System and are currently scheduled to be completed by June 2027. 08 9390 6999 Level 1, 63-69 Abernethy Road, Belmont WA 6104 www.genus.com.au GenusPlus Group Ltd | ABN 86 620 283 561
1
ASX Release 14 October 2026 For immediate release to the market
The customer connection package forms part of the connection of Waddi Wind Farm to the South West Interconnected System in Western Australia’s Mid-West region. The package includes the construction of a new 132kV substation and is currently scheduled to be completed by April 2027. Fortescue Contract Awards Genus has also been awarded two contracts for the design and construction of approximately 60 kilometres of power distribution infrastructure at Fortescue’s Christmas Creek and Solomon mine sites. Fortescue is committed to decarbonising its operations by eliminating Scope 1 and 2 emissions from its Australian terrestrial iron ore operations by the end of 2030. Its decarbonisation plan includes the development of green power generation and distribution. Genus will undertake design and construction of 33kV power distribution infrastructure within Christmas Creek and Solomon mine sites which includes approximately 425 poles, overhead line conductor, underground high voltage cable and associated hardware. Peak onsite manning will be approximately 100 personnel, with site access to be gained in November 2026 and the works estimated to conclude in the fourth quarter of 2027 calendar year. Genus Managing Director, David Riches, said: “Genus is very pleased to have secured these significant contract awards with Western Power, and Fortescue supporting decarbonisation initiatives in Western Australia. The awards reflect the strength of Genus’ capabilities in delivering critical power infrastructure across the utilities and resources sectors and build on our longstanding relationships with both customers. We look forward to safely and efficiently delivering these projects and continuing to support the development of reliable and lower-emissions power infrastructure across Western Australia.” The Board of the Company has authorised the release of this announcement to the market.
08 9390 6999 Level 1, 63-69 Abernethy Road, Belmont WA 6104 www.genus.com.au GenusPlus Group Ltd | ABN 86 620 283 561
2
ASX Release 14 October 2026 For immediate release to the market
ASX Release 12 October 2026 For immediate release to the market
STRATEGIC ACQUISITION OF UCG HOLDINGS HIGHLIGHTS: •
Genus to acquire 100% of Universal Communications Group Holdings Limited (UCG) for an upfront cash consideration of ~NZ$38.25m, deferred cash consideration of ~NZ$1.75m payable over 2 years, and contingent earn-out cash payments of up to NZ$25m subject to FY27 and FY28 adjusted EBIT performance
•
UCG is a leading New Zealand based telecommunications construction and maintenance service provider to Tier 1 telecommunication network owners in New Zealand and the Pacific Islands
•
UCG
has
a
10+
year
relationship
with
Chorus
(NZ’s
largest
telecommunications infrastructure company), and holds a long-term contract to deliver Chorus’ maintenance, build and provisioning works in the upper North Island of New Zealand, including Greater Auckland •
Highly complementary acquisition adds scale and capability to Genus’ telecommunications
offering,
adding
large
scale
communications
network maintenance capability through UCG’s proprietary SiteTRAX workorder management system •
Acquisition also provides Genus with a platform of scale to drive further growth in New Zealand across telecommunications and other critical infrastructure sectors
•
UCG generated unaudited FY26 revenue of approximately NZ$96m and adjusted EBIT of approximately NZ$7.8m
•
Attractive upfront acquisition multiple of 5.1x EV/EBIT (based on NZ$40m upfront and deferred consideration and unaudited FY26A adjusted EBIT of NZ$7.8m), and 5.0x EV/EBIT assuming maximum earnout target is achieved
•
Acquisition expected to be immediately earnings accretive for Genus
•
UCG’s existing KMPs will continue to manage the business, with all staff offered continued employment
Level 1, 63 Abernethy Road, Belmont WA 6104
P: (08) 9390 6999 www.genusplusgroup.com.au
1
ASX Release 12 October 2026 For immediate release to the market
Infrastructure construction, maintenance and service provider, GenusPlus Group Limited (ASX: GNP) (“Genus”, or the “Company”), is pleased to announce it has entered into, through its wholly owned subsidiary Genus Services Pty Ltd (ACN 090 105 141), a binding Share Purchase Agreement (“SPA”) to acquire 100% of Universal Communications Group Holdings Limited (“UCG”). UCG (together with its subsidiaries) is a privately-owned, New Zealand based leading telecommunications construction and maintenance service provider to Tier 1 network owners across New Zealand and the Pacific Islands. UCG’s operating subsidiary was founded in 2013, and has had a 10+ year relationship with Chorus (New Zealand’s largest telecommunications infrastructure company) as part of designing and building out the fibre network in New Zealand. Chorus remains UCG’s key customer today, with a long-term contract to deliver Chorus’ maintenance, build and provisioning works in the upper North Island of New Zealand, including Greater Auckland. UCG employs approximately 150 staff with 6 offices across New Zealand. Based on unaudited management accounts, UCG generated FY26 revenue of approximately NZ$96m, and adjusted EBIT of approximately NZ$7.8m. Genus Managing Director, David Riches, said, “UCG is a highly complementary acquisition that will add scale and capability to our services business and establish a platform for further growth in New Zealand. UCG’s longstanding relationship with Chorus, experienced team and proprietary SiteTRAX workorder management system bring valuable expertise in delivering and maintaining large-scale communications networks. “We look forward to welcoming Ralf, Dillip, and the rest of the UCG team to the Genus family and supporting them as they continue to serve their customers and pursue growth opportunities across New Zealand.” UCG Founder, Ralf Luna, said, “Joining Genus represents an exciting next chapter for UCG. We are proud of the business our team has built and the longstanding customer relationships that underpin it. Becoming part of Genus will give us access to broader capabilities and resources to better support our customers and pursue new opportunities. With our existing management team continuing to lead the business, we look forward to building on these foundations and creating further opportunities for our people.”
Level 1, 63 Abernethy Road, Belmont WA 6104
P: (08) 9390 6999 www.genusplusgroup.com.au
2
ASX Release 12 October 2026 For immediate release to the market
Acquisition Terms In consideration for the acquisition of 100% of UCG, Genus has agreed to pay an upfront cash consideration of ~NZ$38.25m, deferred cash consideration of ~NZ$1.75m payable over 2 years, and contingent earn-out cash payments of up to NZ$25m subject to FY27 and FY28 adjusted EBIT performance. The upfront cash payment is subject to certain customary completion and post-completion adjustments (including for cash, debt, and working capital). The contingent earn-out cash payments of up to NZ$25m across FY27-FY28 is comprised of: •
•
FY27 earn-out: NZ$12.5m subject to achieving FY27 adjusted EBIT of NZ$9.9m o
Nil payable if FY27 adjusted EBIT is NZ$7.6m or below
o
Pro rata if FY27 adjusted EBIT is between NZ$7.6m and NZ$9.9m
o
Full NZ$12.5m payable if FY27 adjusted EBIT is NZ$9.9m or above
FY28 earn-out: NZ$12.5m subject to achieving FY28 adjusted EBIT of NZ$13m o
Nil payable if FY28 adjusted EBIT is NZ$9.9m or below
o
Pro rata if FY28 adjusted EBIT is between NZ$9.9m and NZ$13m
o
Full NZ$12.5m payable if FY28 adjusted EBIT is NZ$13m or above
The acquisition will be funded from Genus’ existing cash balance and its existing syndicated debt facility. Conditions Precedent Completion of the acquisition under the SPA is subject to certain conditions precedent, including but not limited to those set out below, being satisfied or waived: •
Receipt of change of control consents for UCG’s material contracts and property leases
•
Receipt of a direction order from the New Zealand Overseas Investment Office
Completion of the acquisition is indicatively anticipated for end of October 2026. If the conditions precedent are not satisfied or waived within 40 business days from execution of the SPA, the SPA can be terminated, unless extended. Advisers Sternship Advisers acted as corporate adviser to Genus. Quigg Partners acted as New Zealand legal advisers and Gilbert + Tobin as Australian legal advisers to Genus. RSM Australia acted as financial due diligence adviser, and RSM New Zealand acted as tax due diligence adviser to Genus.
Level 1, 63 Abernethy Road, Belmont WA 6104
P: (08) 9390 6999 www.genusplusgroup.com.au
3
ASX Release 12 October 2026 For immediate release to the market
The Board of the Company has authorised the release of this announcement to the market.
ASX Release 2 October 2026 For immediate release to the market
GENUS RECEIVES NOTICE TO PROCEED FOR THE PARRON FARM PROJECT Infrastructure construction, maintenance and service provider GenusPlus Group Ltd (ASX: GNP) (Genus, or the Company) refers to its ASX Announcement dated 24th September 2026 in relation to the award of the Design and Construct contract (Contract) by Atmos Renewables relating to the works within the 330kV Parron Maam Marang Farm Substation. Genus is pleased to announce that the conditions precedent referred to in that ASX announcement have been met and Genus has now received the Notice to Proceed with the works under the Contract to commence immediately.
The Board of the Company has authorised the release of this announcement to the market.
Appendix 2A - Application for quotation of securities
Announcement Summary
Entity name GENUSPLUS GROUP LTD Announcement Type New announcement Date of this announcement Monday September 28, 2026 The +securities to be quoted are: +Securities issued under an +employee incentive scheme that are not subject to a restriction on transfer or that are to be quoted notwithstanding there is a restriction on transfer Total number of +securities to be quoted ASX +security code
Security description
GNP
ORDINARY FULLY PAID
Number of +securities to be quoted
Issue date
279,548
25/09/2026
Refer to next page for full details of the announcement
Appendix 2A - Application for quotation of securities
1/7
Appendix 2A - Application for quotation of securities
Part 1 - Entity and announcement details
1.1 Name of entity GENUSPLUS GROUP LTD We (the entity named above) apply for +quotation of the following +securities and agree to the matters set out in Appendix 2A of the ASX Listing Rules. 1.2 Registered number type
Registration number
ACN
620283561
1.3 ASX issuer code GNP 1.4 The announcement is New announcement 1.5 Date of this announcement 28/9/2026
Appendix 2A - Application for quotation of securities
2/7
Appendix 2A - Application for quotation of securities
Part 2 - Type of Issue
2.1 The +securities to be quoted are: +Securities issued under an +employee incentive scheme that are not subject to a restriction on transfer or that are to be quoted notwithstanding there is a restriction on transfer 2.2 The +class of +securities to be quoted is: Additional +securities in a class that is already quoted on ASX ("existing class")
Appendix 2A - Application for quotation of securities
3/7
Appendix 2A - Application for quotation of securities
Part 3B - number and type of +securities to be quoted (existing class) where issue has not previously been notified to ASX in an Appendix 3B
Additional +securities to be quoted in an existing class issued under an +employee incentive scheme FROM (Existing Class) ASX +security code and description GNPAB : PERFORMANCE RIGHTS
TO (Existing Class) ASX +security code and description GNP : ORDINARY FULLY PAID
Please state the number of +securities issued under the +employee incentive scheme that are not subject to a restriction on transfer or that are to be quoted notwithstanding there is a restriction on transfer 279,548 Please provide details of a URL link for a document lodged with ASX detailing the terms of the +employee incentive scheme or a summary of the terms https://asx.api.cmfyapp.com/asx-research/1.0/file/2924-02728673-6A1175610&v=undefined Are any of these +securities being issued to +key management personnel (KMP) or an +associate Yes Provide details of the KMP or +associates being issued +securities Name of KMP
Name of registered holder
Number of +securities
Kevin Arnold
Tanya Leigh Arnold
61,380
Issue date 25/9/2026 Will the +securities to be quoted rank equally in all respects from their issue date with the existing issued +securities in that class? Yes
Appendix 2A - Application for quotation of securities
4/7
Appendix 2A - Application for quotation of securities Issue details
Number of +securities to be quoted 279,548 Are the +securities being issued for a cash consideration? No Please describe the consideration being provided for the +securities 279,548 ordinary securities issued pursuant to the exercise of 279,548 unlisted performance rights, each with a nil exercise price Please provide an estimate (in AUD) of the value of the consideration being provided per +security for the +securities to be quoted 8.140000 Any other information the entity wishes to provide about the +securities to be quoted
Appendix 2A - Application for quotation of securities
5/7
Appendix 2A - Application for quotation of securities
Part 4 - Issued capital following quotation
Following the quotation of the +securities the subject of this application, the issued capital of the entity will comprise: The figures in parts 4.1 and 4.2 below are automatically generated and may not reflect the entity's current issued capital if other Appendix 2A, Appendix 3G or Appendix 3H forms are currently with ASX for processing. 4.1 Quoted +securities (total number of each +class of +securities quoted on ASX following the +quotation of the +securities subject of this application) ASX +security code and description
Total number of +securities on issue
GNP : ORDINARY FULLY PAID
203,597,160
4.2 Unquoted +securities (total number of each +class of +securities issued but not quoted on ASX) ASX +security code and description
Total number of +securities on issue
GNPAB : PERFORMANCE RIGHTS
1,693,407
GNPAC : SHARE APPRECIATION RIGHTS
1,153,126
GNPAA : RETENTION RIGHTS
Appendix 2A - Application for quotation of securities
35,914
6/7
Appendix 2A - Application for quotation of securities
Part 5 - Other Listing Rule requirements
5.1 Are the +securities being issued under an exception in Listing Rule 7.2 and therefore the issue does not need any security holder approval under Listing Rule 7.1? Yes 5.1a Select the number of the applicable exception in Listing Rule 7.2 13
Appendix 2A - Application for quotation of securities
7/7
ASX Release 24 September 2026 For immediate release to the market
GENUS AWARDED CONTRACT AS PART OF THE PARRON FARM PROJECT HIGHLIGHTS: •
Genus awarded Design and Construct Contract by Atmos Renewables for works associated with the Parron Maam Marang Farm
•
Contract includes the 330kV terminal, 330kV transmission lines and associated ancillary works
•
Total contract value at approximately $135 million
•
Works expected to be completed in 2028
Infrastructure construction, maintenance and service provider GenusPlus Group Ltd (ASX: GNP) (Genus, or the Company) is pleased to announce that it has been awarded a Design and Construct contract (Contract) by Atmos Renewables to deliver a 330kV Terminal, 330kV Transmission Lines Works and associated ancillary works within the 330kV Parron Maam Marang Farm Substation. Work under the Construction Phase is subject to customary conditions precedent, including Atmos Renewables achieving project financial close, executing Connection Agreements, and the issuance of the Notice to Proceed. The work is scheduled for completion in 2028. The Contract is part of the overall 470MW Parron Maam Marang Farm Project (Project) and is located in Badgingarra in Western Australia. Genus has performed some preliminary early works at the Project, including detailed design, procurement of long-lead items and bulk earthworks, with the total contract value for the Contract, including the early works, having a value of circa $135 million. Genus Managing Director, David Riches, said Genus is very pleased to be working with Atmos on the delivery of this wind farm connection in Western Australia. The Project is supported through the Federal Government’s flagship Capacity Investment Scheme (CIS) as the state prepares to exit coal-fired power by 2030. “Genus has worked closely with Atmos and is pleased to have been selected by Atmos Renewables to deliver this important package of electrical infrastructure works for the Parron Maam Marang Farm. This Contract builds on our relationship with Atmos continuing on from the Merredin BESS Project. It is a strong endorsement of our delivery performance and the resilience of our customer relationships, reinforcing our position as a trusted long‑term partner. We look forward to again working closely with Atmos and bringing our extensive transmission and energy 08 9390 6999 Level 1, 63-69 Abernethy Road, Belmont WA 6104 www.genus.com.au GenusPlus Group Ltd | ABN 86 620 283 561
1
ASX Release 24 September 2026 For immediate release to the market
infrastructure capability to the project. and delivering the grid connection for this critical infrastructure for Western Australia. By combining Genus’ capability, local experience and expertise, we can deliver lasting value for the community”. The Board of the Company has authorised the release of this announcement to the market.
ASX Release 16 September 2026 For Immediate Release
DATE OF AGM AND CLOSING DATE FOR DIRECTOR NOMINATIONS In accordance with listing rule 3.13.1, GenusPlus Group Limited (ASX: GNP) (the “Company”) advises that its Annual General Meeting (AGM) will be held at 10:00am (Perth time) on Friday 20th November 2026 at the offices of Grant Thornton, Level 43, 152-158 St Georges Terrace, Perth, Western Australia. An item of business at the AGM will be the re-election of directors. In accordance with the Company's Constitution, the closing date for the receipt of nominations from persons wishing to be considered for election as a director is 13 October 2026, and any nominations must be received at the Company's registered office no later than 5:00pm on that day. The notice of the AGM will be issued in due course. This announcement has been authorised for release by the Company Secretary.
HIGHLIGHTS: •
Genus awarded contract to deliver a 400 MW / 1.86 GWh Battery Energy Storage System (BESS) in Victoria for a leading renewable energy investment manager
•
Construction is scheduled for completion by late 2028
•
Contract value is approximately $160 million
GenusPlus Group Limited (ASX: GNP) (“Genus”) is pleased to announce that it has been awarded a contract to deliver a 400 MW / 1.86 GWh Battery Energy Storage System (BESS) in Victoria for Birdwood Energy Reserve (“Birdwood”) in Victoria. The project is located at Wodonga in Victoria and represents a significant addition to Genus’ growing portfolio of large-scale renewable energy and energy storage infrastructure projects. Construction is scheduled for completion in late 2028. The contract value is approximately $160 million. Under the contract, Genus will deliver the Balance of Plant works including civil, structural and electrical infrastructure, high-voltage connection assets, communications and control systems, and testing and commissioning, leveraging its extensive capabilities across engineering, procurement, construction, high-voltage infrastructure. The project further strengthens Genus’ position as a leading provider of critical energy infrastructure and builds on the Group’s established capability in delivering large-scale battery energy storage projects across Australia. GenusPlus Group Managing Director David Riches said: “This project is another significant milestone for Genus and demonstrates the strength of our capabilities in delivering the critical infrastructure required to support Australia’s energy transition. “At 400 MW / 1.86 GWh, this is a substantial battery project that will play an important role in storing renewable energy and making it available when it is needed most.
08 9390 6999 Level 1, 63-69 Abernethy Road, Belmont WA 6104 www.genus.com.au GenusPlus Group Ltd | ABN 86 620 283 561
1
ASX Release 14th September 2026 For immediate release to the market
“We are proud to be partnering with Birdwood to deliver this project and look forward to drawing on the depth of capability across the Genus Group to safely and successfully deliver the project
INDEX ANNOUNCEMENT
S&P Dow Jones Indices Announces September 2026 Quarterly Rebalance of the S&P/ASX Indices SYDNEY, SEPTEMBER 4, 2026: S&P Dow Jones Indices announced today the changes in the S&P/ASX Indices, effective prior to the open of trading on Monday, September 21, 2026, as a result of the September quarterly review. S&P/ASX 20 Index – No change.
S&P/ASX 50 Index – Effective Prior to the Open on September 21, 2026 Action
Code
Company
Addition
MIN
Mineral Resources Limited
Addition
NXT
NEXTDC Limited
Removal
COH
Cochlear Limited
Removal
WTC
WiseTech Global Limited
S&P/ASX 100 Index – Effective Prior to the Open on September 21, 2026 Action
Code
Company
Addition
CDA
Codan Limited
Removal
ALX
Atlas Arteria
S&P/ASX 200 Index – Effective Prior to the Open on September 21, 2026 Action
Code
Company
Addition
ELS
Elsight Limited
Addition
SIQ
Smartgroup Corporation Limited
Addition
SRL
Sunrise Energy Metals Limited
Addition
SSM
Service Stream Limited
Addition
WBT
Weebit Nano Limited
Removal
EVT
EVT Limited
Removal
GNC
GrainCorp Limited
Removal
GQG
GQG Partners Inc.
Removal
PNR
Pantoro Gold Limited
Removal
TUA
Tuas Limited
S&P/ASX 300 Index – Effective Prior to the Open on September 21, 2026 Action
Code
Company
Addition
AYA
Artrya Limited
Addition
BNZ
Benz Mining Corp.
Addition
BRE
Brazilian Rare Earths Limited
Addition
CCL
Cuscal Limited
Addition
CXO
Core Lithium Limited
Addition
EIQ
Echo IQ Limited
Addition
EQR
Eq Resources Limited
Addition
GNG
Gr Engineering Services Limited
Addition
GNP
GenusPlus Group Limited
Addition
IMR
Imricor Medical Systems Inc.
Addition
LIN
Lindian Resources Limited
Addition
NGI
Navigator Global Investments Limited
Addition
PYC
PYC Therapeutics Limited
Addition
SKS
SKS Technologies Group Limited
Addition
SXE
Southern Cross Electrical Engineering Limited
INDEX ANNOUNCEMENT
Addition
TEA
Tasmea Limited
Removal
AFG
Australian Finance Group Limited
Removal
BAP
Bapcor Limited
Removal
DTR
Dateline Resources Limited
Removal
GEM
G8 Education Limited
Removal
GTK
Gentrack Group Limited
Removal
HLS
Healius Limited
Removal
IMM
Immutep Limited
Removal
JIN
Jumbo Interactive Limited
Removal
LOT
Lotus Resources Limited
Removal
MEK
Meeka Metals Limited
Removal
MYR
Myer Holdings Limited
Removal
OCL
Objective Corporation Limited
Removal
PFP
Propel Funeral Partners Limited
All Ordinaries – Effective Prior to the Open on September 21, 2026 Action
Code
Company
Addition
AGE
Alligator Energy Limited
Addition
AI1
Adisyn Limited
Addition
ALR
Altair Minerals Limited
Addition
AS1
Asara Resources Limited
Addition
BLS
BLS Pharmaceuticals Limited
Addition
BM1
Ballard Mining Limited
Addition
BMC
BMC Minerals Limited
Addition
CBE
Cobre Limited
Addition
CEN
ASX Release 31 August 2026 For immediate release to the market
CONSTRUCTION TO BEGIN ON TASNETWORKS NORTH WEST TRANSMISSION DEVELOPMENTS (NWTD) STAGE 1 PROJECT HIGHLIGHTS: •
Notice to Proceed with Construction Phase issued by TasNetworks
•
Work under Construction Phase to commence immediately and scheduled for completion in 2029
•
Total works valued at circa $750 million including the ECI and EWA valued at $122 million
Infrastructure construction, maintenance and service provider GenusPlus Group Ltd (ASX: GNP) (Genus, or the Company) refers to its ASX announcements dated 24 December 2024, 28 April 2026 and 8 May 2026. Genus is pleased to advise that all conditions to which the Construction Phase of Stage 1 of TasNetworks’ North West Transmission Developments (NWTD) project was subject to have now been met, with TasNetworks having issued a Notice to Proceed to Genus. Work under the Construction Phase will commence immediately and is scheduled for completion in 2029. Genus has previously announced Early Contractor Involvement (ECI) and Early Works Agreements (EWA) valued at $122 million (including the procurement of long-lead items), with the total contract value for the Project including the ECI and EWA Phase having a value of circa $750 million. Genus Managing Director, David Riches, said Genus is very pleased to be working with TasNetworks on the delivery of this important project in Tasmania. “Genus has worked closely with TasNetworks to reach this important milestone; and with the start of construction imminent we’re proud to move into the next phase of delivering this critical infrastructure for Tasmania and Australia. We’re committed to creating opportunities for Tasmanians throughout the project, from employing local people to engaging Tasmanian business and suppliers. By combining Genus’ capability and experience with local knowledge and expertise, we can deliver lasting value for the community”.
The Board of the Company has authorised the release of this announcement to the market. 08 9390 6999 Level 1, 63-69 Abernethy Road, Belmont WA 6104 www.genus.com.au GenusPlus Group Ltd | ABN 86 620 283 561
1
ASX Release 31 August 2026 For immediate release to the market
ASX Release 25 August 2026 For immediate release to the market.
GENUSPLUS GROUP – FINANCIAL RESULTS FOR FY2026 HIGHLIGHTS: •
Record Revenue of $1.281 billion – up 70.5% on PCP of $751.3 million.
•
Record Normalised EBITDA of $100.8 million – up 49.6% on PCP of $67.4 million.
•
Underlying NPAT of $54.7 million – up 44.0% on PCP of $38.0 million.
•
Cash inflow from operations of $194.0 million.
•
Cash balance of $476.0 million up from $160.9 million at June 2025 and net cash of $399.3 million up from $113.5 million at June 2025. Cash includes net proceeds of equity raise completed in May 2026 of $195.6 million.
•
Basic earnings per share of 26.75 cents per share up 35.5% on PCP.
•
Final Dividend declared of 3.6 cents per share fully franked to be paid 30th October 2026. Total dividends for the year of 5.6 cents per share up 55.6% on PCP.
•
Orderbook of $2.2 billion (excluding recurring revenue).
•
Recurring revenue forecast $764 million in FY2027 (including MPK).
•
Strong tendered pipeline at $3.6 billion.
•
Forecast EBITDA for FY2027 to be in the range of $200-205 million.
National essential power and communications infrastructure provider GenusPlus Group Ltd (ASX: GNP) (GenusPlus or the Company) has today reported revenue of $1.281 billion; up 70.5% from $751.3 million in FY2025, and normalised EBITDA of $100.8 million for FY2026; up 49.6% from $67.4 million in FY2025.
Profit & Loss Statement (A$ millions)
FY2025
FY2026
Change %
Revenue
751.3
1,281.1
70.5%
65.1
95.8
67.4
100.8
EBITDA
1
EBITDA Normalised
1
49.6%
53.2
76.3
55.5
81.3
NPAT
35.4
49.0
38.5%
Underlying NPAT3
38.0
54.9
44.5%
EBIT-A
2
EBIT-A Normalised
1
46.5%
Note: These are non-IFRS measures that are unaudited but derived from audited FY26 Financial Statements. These measures are presented to provide further insight into GenusPlus Group’s performance. 1.
FY2026 Normalised EBITDA / EBIT-A excluding Acquisition costs of $5 million, Commtel restructuring costs of $0.6 million and ECM claims revenue of ($0.5) million. FY2025 Normalised EBITDA / EBIT-A excluding Acquisition costs of $1.7 million and costs from ECM claims of $0.6 million.
EBIT-A is adjusted for amortisation of acquisition intangibles.
Underlying NPAT is NPAT excluding acquisition costs and amortisation of acquisition intangibles.
GenusPlus Group Ltd | ABN 86 620 283 561
1
ASX Release 25 August 2026 For immediate release to the market.
The Group has maintained a strong liquidity position, with cash of $476.0 million, up from $160.9 million at June 2025 and net cash of $399.3 million up from $113.5 million at June 2025. Cash includes $195.6 million received from equity raise completed in May 2026 for the acquisition of MPK which completed on 1 July 2026 with borrowings drawn of $130 million.
Bank Guarantee and Surety Bond limits have increased to $540 million (up from $260 million at 30 June 2025) with $296.3 million headroom available at 30 June 2026. Further details of the year result can be found in the Appendix 4E and the Annual Financial Report released today.
DIVIDENDS The Directors have declared a Final Dividend of 3.6 cents per share to be paid on 30th October 2026. This brings total dividends for the year to 5.6 cents per share, up 55.6% from FY2025.
OPERATIONAL PERFORMANCE Commenting on the performance of the business, David Riches, GenusPlus Managing Director said: “The business has delivered exceptional results in FY2026 with record revenue, EBITDA and NPAT. Additionally, the group continued to see a very strong orderbook with significant renewable energy and Rewiring the Nation projects moving into execution. The tailwinds for the Infrastructure and Energy and Engineering segment are significant as Australia transitions to new clean energy generation, which requires significant investment in the transmission network across the country. Integration of acquisitions has progressed as planned throughout FY2026, with the integration and synergies of these acquisitions proceeding well with expectations being met. The MGC integration is nearing completion, positioning the business for growth. Commtel has been integrated into the Group and now operates under a strengthened management structure following the acquisition of the business out of administration. Safety is the Company’s highest priority, and the team achieved a Total Recordable Injury Frequency Rate (TRIFR) of 2.6 for the 12 months to 30 June 2026. I would like to thank the efforts of our dedicated 2,500 plus staff, and subcontractors, as they have been key in continuing to safely deliver to our valued clients. We welcome MPK and its 900-plus staff to the Genus team and look forward to working together to build a stronger group. Our staff are our key asset to drive the success of Genus.”
OUTLOOK Strong momentum generated in FY2026, the acquisition of MPK and Railtrain, combined with a strong orderbook of $2.2 billion, provides a solid base to support earnings growth in FY2027. Genus is forecasting EBITDA to be $200-205 million in FY2027. The Group expects to see continued growth from its east coast operations and increase in services revenue in FY2027. Recurring revenue has continued to grow and is forecast to be circa $764 million in FY2027 (including MPK), up from $446 million in FY2026. The increased demand on the power network around Australia should see a multidecade pipeline of transmission and distribution projects connecting Australia’s energy future as the nation goes through a substantial transition from the traditional energy source of coal to generation from new and renewable energy. The growth in the data centre market with additional energy requirements will continue to provide Genus with a positive outlook for many years to come.
GenusPlus Group Ltd | ABN 86 620 283 561
2
ASX Release 25 August 2026 For immediate release to the market.
The transition requires investment in renewable energy, supported by battery storage and reconfiguration of transmission and distribution networks. Genus is well placed to participate in this thematic having delivered multiple transmission and distribution networks, solar farms and battery energy storage systems, which will play a critical role in the decarbonisation of Australia. With a strong orderbook of $2.2 billion and a growing tendered pipeline of $3.6 billion the outlook remains positive.
GROWTH STRATEGY Significant investment has been put into growing the east coast presence and diversifying the capabilities of Genus in complimentary industries of gas, water and rail. Genus’ east coast footprint is expected to exceed 50% following the acquisition of MPK. Genus has positioned itself to benefit from the substantial investment required across Australia's essential infrastructure networks over the next 10-20 years. Genus is forecasting FY2027 CAPEX to be in the range of $65 - $70 million (including MPK and Railtrain). Genus will continue to explore M&A opportunities, We are well advanced with integrating our recent rail acquisitions and are progressing through the MPK integration within the Group.
RESULTS PRESENTATION Investors and analysts are invited to attend a results presentation with Managing Director, David Riches today, Tuesday 25 August 2026 at 10:00am AWST/12:00pm AEDT. Investors and analysts can register to attend at the following links: Pre-Registration Link: https://zoom.us/meeting/register/41Qxy08qSc-HBpsYSe65dw
The Board of the Company has authorised the release of this announcement to the market.
H
FY2026 RESULTS PRESENTATION For the 12 months ended 30 June 2026
THINK SAFE | WORK SAFE | HOME SAFE
INVESTOR PRESENTATION | FY2026
CONTENTS OUR COMPANY
H
2
2
03 |
FY2026 Executive Summary
04 |
Key Messages
05 |
FY2026 Financial Highlights
06 |
FY2027 Outlook
07 |
MPK Acquisition
08 |
Historical Performance
09 |
Financial Overview
10 |
Financial Position
11 |
Cash Flow Summary
12 |
Segments
ADDITONAL INFORMATION 20 |
Corporate Overview
21 |
Appendix
FY2026 EXECUTIVE SUMMARY 2,503
$1.281b
2.6
$2.2b
Employees
Revenue
TRIFR
Orderbook
162 Apprentices and Trainees
REVENUE BY SECTOR
Infrastructure
$837.4m
▲ Up 101.5% on PCP
Energy & Engineering
$368.7m
▲ Up 57.2% on PCP
Services
$152.2m 3
▲ Up 23.5% on PCP
Bringing together industry-leading expertise and sector experience, Delivering comprehensive services and projects across the entire infrastructure lifecycle in the Transport, Water, Power, and Oil & Gas sectors. From planning, design and construction to testing, maintenance and commissioning, we provide reliable, future-ready solutions tailored to the evolving needs of critical infrastructure networks.
Delivering end-to-end Engineering, Procurement, and Construction (EPC) solutions, offering a comprehensive range of in-house design capabilities across communications and energy assets. Our expertise spans from concept and design through to construction and commissioning—ensuring seamless integration, efficiency, and quality in every phase.
Providing integrated infrastructure solutions across communications, vegetation management, environmental services, pole reinforcement and asset management integrating technical expertise with operational delivery.
3
KEY MESSAGES GENUS A MAJOR DIVERSIFIED AUSTRALIAN INFRASTRUCTURE SERVICE PROVIDER Stable leadership and management have navigated strong YoY growth while maintaining strong retention, with a continued focus on strengthening the organisation and building the foundations for future growth.
Successfully scaled from $551m to $1.28b in revenue
Appendix 3A.1 - Notification of dividend / distribution
Announcement Summary
Entity name GENUSPLUS GROUP LTD Security on which the Distribution will be paid GNP - ORDINARY FULLY PAID Announcement Type New announcement Date of this announcement 25/8/2026 Distribution Amount AUD 0.03600000 Ex Date 30/9/2026 Record Date 1/10/2026 Payment Date 30/10/2026 Additional Information Not applicable Refer to below for full details of the announcement
Appendix 3A.1 - Notification of dividend / distribution
1/4
Appendix 3A.1 - Notification of dividend / distribution
Announcement Details
Part 1 - Entity and announcement details
1.1 Name of +Entity GENUSPLUS GROUP LTD 1.2 Registered Number Type
Registration Number
ACN
620283561
1.3 ASX issuer code GNP 1.4 The announcement is New announcement 1.5 Date of this announcement 25/8/2026 1.6 ASX +Security Code GNP ASX +Security Description ORDINARY FULLY PAID
Part 2A - All dividends/distributions basic details
2A.1 Type of dividend/distribution Ordinary 2A.2 The Dividend/distribution: relates to a period of six months 2A.3 The dividend/distribution relates to the financial reporting or payment period ending ended/ending (date) 30/6/2026 2A.4 +Record Date 1/10/2026 2A.5 Ex Date 30/9/2026 2A.6 Payment Date 30/10/2026 2A.7 Are any of the below approvals required for the dividend/distribution before business day 0 of the timetable? Security holder approval Court approval Lodgement of court order with +ASIC ACCC approval FIRB approval Appendix 3A.1 - Notification of dividend / distribution
2/4
Appendix 3A.1 - Notification of dividend / distribution FIRB approval Another approval/condition external to the entity required before business day 0 of the timetable for the dividend/distribution. No 2A.8 Currency in which the dividend/distribution is made ("primary currency") AUD - Australian Dollar 2A.9 Total dividend/distribution payment amount per +security (in primary currency) for all dividends/distributions notified in this form AUD 0.03600000
2A.10 Does the entity have arrangements relating to the currency in which the dividend/distribution is paid to securityholders that it wishes to disclose to the market? No 2A.11 Does the entity have a securities plan for dividends/distributions on this +security? We do not have a securities plan for dividends/distributions on this security
2A.12 Does the +entity have tax component information apart from franking? No
Part 3A - Ordinary dividend/distribution
3A.1 Is the ordinary dividend/distribution estimated at this time? No
3A.1a Ordinary dividend/distribution estimated amount per +security AUD
3A.1b Ordinary Dividend/distribution amount per security AUD 0.03600000 3A.2 Is the ordinary dividend/distribution franked? Yes
3A.2a Is the ordinary dividend/distribution fully franked? Yes
3A.3 Percentage of ordinary dividend/distribution that is 3A.3a Applicable corporate tax rate for franking credit franked (%) 100.0000 %
30.0000 %
3A.4 Ordinary dividend/distribution franked amount per +security
3A.5 Percentage amount of dividend which is unfranked 0.0000 %
AUD 0.03600000 3A.6 Ordinary dividend/distribution unfranked amount per +security excluding conduit foreign income amount AUD 0.00000000
3A.7 Ordinary dividend/distribution conduit foreign Appendix 3A.1 - Notification of dividend / distribution
3/4
Appendix 3A.1 - Notification of dividend / distribution 3A.7 Ordinary dividend/distribution conduit foreign income amount per security AUD 0.00000000
Part 5 - Further information
5.1 Please provide any further information applicable to this dividend/distribution Not applicable 5.2 Additional information for inclusion in the Announcement Summary Not applicable
Appendix 3A.1 - Notification of dividend / distribution
4/4
Prompts
Click prompts to add them under the company line, click again to take one out, then copy the result into your AI chat. Shared by Asian Century Stocks and Uncovered Thai Stocks. Thank you.
ETFs Holding GenusPlus Group Ltd
Exchange-traded funds whose newest published daily portfolio holds one of the company's listings, largest weight first.
| ETF | Weight in ETF | Shares | Market value | As of |
|---|---|---|---|---|
| AVDS | 0.03% | 19,001 | $ 108.491K | Nov 16, 2026 |
| AVDV | 0.01% | 231,625 | $ 1.323M | Nov 16, 2026 |
| AVSD | 0.01% | 5,092 | $ 29.074K | Nov 16, 2026 |
| DFIS | 0.01% | 84,283 | $ 506.239K | Nov 12, 2026 |
| DFIC | 0.00% | 32,849 | $ 197.305K | Nov 12, 2026 |
| DFSI | 0.00% | 2,212 | $ 13.286K | Nov 12, 2026 |
| DFAI | 0.00% | 24,636 | $ 147.974K | Nov 12, 2026 |
| DFAX | 0.00% | 5,817 | $ 34.939K | Nov 12, 2026 |
| AVDE | 0.00% | 123,915 | $ 707.523K | Nov 16, 2026 |